<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants - Darlow, BA - 2016 | Cochrane Library</title> <meta content="Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants - Darlow, BA - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000501.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants - Darlow, BA - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000501.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000501.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants" name="citation_title"/> <meta content="Brian A Darlow" name="citation_author"/> <meta content="University of Otago" name="citation_author_institution"/> <meta content="brian.darlow@otago.ac.nz" name="citation_author_email"/> <meta content="P J Graham" name="citation_author"/> <meta content="Christchurch School of Medicine" name="citation_author_institution"/> <meta content="Maria Ximena Rojas‐Reyes" name="citation_author"/> <meta content="Pontificia Universidad Javeriana" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD000501.pub4" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/08/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000501.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000501.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000501.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Infant, Very Low Birth Weight; Infant, Premature; Infant, Premature, Diseases [mortality, *prevention &amp; control]; Lung Diseases [mortality, *prevention &amp; control]; Randomized Controlled Trials as Topic; Vitamin A [*therapeutic use]; Vitamins [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000501.pub4&amp;doi=10.1002/14651858.CD000501.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="Ko3zGe0H";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000501\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000501\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ko","ms","ja","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000501.pub4",title:"Vitamin A supplementation to prevent mortality and short\\u2010 and long\\u2010term morbidity in very low birth weight infants",firstPublishedDate:"Aug 22, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Ko3zGe0H&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000501.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000501.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000501.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000501.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000501.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000501.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000501.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000501.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000501.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000501.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5192 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000501.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-sec-0115"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-sec-0064"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-sec-0114"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/appendices#CD000501-sec-0120"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/table_n/CD000501StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/table_n/CD000501StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birth weight infants </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information#CD000501-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Brian A Darlow</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information#CD000501-cr-0003">P J Graham</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information#CD000501-cr-0004">Maria Ximena Rojas‐Reyes</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information/en#CD000501-sec-0126">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 August 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000501.pub4">https://doi.org/10.1002/14651858.CD000501.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000501-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000501-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000501-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000501-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000501-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000501-abs-0003">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000501-abs-0002">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000501-abs-0001" lang="en"> <section id="CD000501-sec-0001"> <h3 class="title" id="CD000501-sec-0001">Background</h3> <p>Vitamin A is necessary for normal lung growth and the integrity of respiratory tract epithelial cells. Preterm infants have low vitamin A status at birth and this has been associated with an increased risk of developing chronic lung disease. </p> </section> <section id="CD000501-sec-0002"> <h3 class="title" id="CD000501-sec-0002">Objectives</h3> <p>To evaluate supplementation with vitamin A on the incidence of death or neonatal chronic lung disease and long‐term neurodevelopmental disability in very low birth weight (VLBW) infants compared with a control (placebo or no supplementation), and to consider the effect of the supplementation route, dose, and timing. </p> </section> <section id="CD000501-sec-0003"> <h3 class="title" id="CD000501-sec-0003">Search methods</h3> <p>For the original review and subsequent updates, we searched the Cochrane Central Register of Controlled Trials (CENTRAL, <i>The Cochrane Library</i>), MEDLINE, Science Citation Index, and the Oxford Database of Perinatal Trials. The reference lists of relevant trials, paediatric and nutrition journals, and conference abstracts and proceedings were handsearched up to 2010. </p> <p>For the 2016 update, we used the standard search strategy of the Cochrane Neonatal Review group to search the Cochrane Central Register of Controlled Trials (CENTRAL 2016, Issue 4), MEDLINE via PubMed (1 May 2016), EMBASE (1 May 2016), and CINAHL (1 May 2016). We also searched clinical trials' databases, conference proceedings, and the reference lists of retrieved articles for randomised controlled trials and quasi‐randomised trials. </p> </section> <section id="CD000501-sec-0004"> <h3 class="title" id="CD000501-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing vitamin A supplementation with a control (placebo or no supplementation) or other dosage regimens in VLBW infants (birth weight ≤ 1500 grams or less than 32 weeks' gestation). </p> </section> <section id="CD000501-sec-0005"> <h3 class="title" id="CD000501-sec-0005">Data collection and analysis</h3> <p>Two review authors screened the search results, extracted data, and assessed the trials for risk of bias. Results were reported as risk ratios (RR), risk differences (RD), and number needed to treat to benefit (NNTB), all with 95% confidence intervals (CI). Trialists were contacted for additional data. </p> </section> <section id="CD000501-sec-0006"> <h3 class="title" id="CD000501-sec-0006">Main results</h3> <p>Eleven trials met the inclusion criteria. Ten trials (1460 infants) compared vitamin A supplementation with a control and one (120 infants) compared different regimens of vitamin A supplementation. Compared to the control group, vitamin A appeared to have a small benefit in reducing the risk of death or oxygen requirement at one month of age (typical RR 0.93, 95% CI 0.88 to 0.99; typical RD −0.05, 95% CI −0.10 to −0.01; NNTB 20, 95% CI 10 to 100; 6 studies, 1165 infants) and the risk of chronic lung disease (oxygen requirement) at 36 weeks' postmenstrual age (typical RR 0.87, 95% CI 0.77 to 0.99; typical RD −0.07, 95% CI −0.13 to −0.01; NNTB 11, 95% CI 6 to 100; 5 studies, 986 infants) (moderate‐quality evidence). There was a marginal reduction of the combined outcome of death or chronic lung disease (typical RR 0.92, 95% CI 0.84 to 1.01; typical RD −0.05, 95% CI −0.11 to 0.01; 4 studies, 1089 infants). Neurodevelopmental assessment of 88% of the surviving infants in the largest trial showed no difference between the groups at 18 to 22 months of age, corrected for prematurity (low‐quality evidence). There is no evidence to support different vitamin A dosing regimens. No adverse effects of vitamin A supplementation were reported, but it was noted that intramuscular injections of vitamin A were painful. </p> </section> <section id="CD000501-sec-0007"> <h3 class="title" id="CD000501-sec-0007">Authors' conclusions</h3> <p>Whether clinicians decide to utilise repeat intramuscular doses of vitamin A to prevent chronic lung disease may depend upon the local incidence of this outcome and the value attached to achieving a modest reduction in the outcome balanced against the lack of other proven benefits and the acceptability of the treatment. Information on long‐term neurodevelopmental status suggests no evidence of either benefit or harm from the intervention. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000501-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000501-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000501-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000501-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000501-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000501-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000501-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000501-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000501-abs-0007">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000501-abs-0006" lang="en"> <h3>Vitamin A supplementation to prevent deaths and short‐ and long‐term illness in very low birth weight infants </h3> <p><b>Review question:</b> Does supplementation with vitamin A prevent death, chronic lung injury and long‐term neurodevelopmental disability in very low birth weight infants compared with a control (placebo or no supplementation)? </p> <p><b>Background:</b> Vitamin A is a group of fat‐soluble compounds used by the body for regulation and promotion of growth and differentiation of many cells, including cells in the retina of the eye and the cells that line the air passages in the lungs. Preterm infants have low vitamin A levels at birth. This may contribute to an increased risk of developing chronic lung disease and hence a requirement for oxygen. It is possible that an additional vitamin A supplement may reduce complications of prematurity, including abnormal development of the retina (retinopathy), bleeding in the brain (intraventricular haemorrhage), and damage to the gut from inflammation (necrotising enterocolitis) as well as reducing respiratory infections. Too much vitamin A is potentially harmful as it can raise intracranial pressure and cause skin and mucous membrane changes (injury or lesions), and vomiting. </p> <p><b>Study characteristics:</b> Eleven trials were included in this review, ten comparing vitamin A with a control (placebo or no supplementation) and one comparing different vitamin A regimens. The search for eligible trials was updated in May 2016. </p> <p><b>Results:</b> Compared to the control group, supplementing very low birth weight infants with vitamin A appears to have a small benefit in reducing the risk of death or oxygen requirement at one month of age and the risk of chronic lung disease (oxygen requirement) at 36 weeks' postmenstrual age (moderate‐quality evidence). There was a marginal reduction of the combined outcome of death or chronic lung disease (moderate‐quality evidence). Although there is a statistical reduction in chronic lung disease, these findings are consistent with either a meaningful impact on chronic lung disease or a negligible impact. The one trial that investigated neurodevelopmental status at 18 to 22 months of age correcting for prematurity found no evidence of benefit or harm associated with vitamin A supplementation compared to control (low‐quality evidence). No adverse effects of vitamin A supplementation were reported, but it was noted that intramuscular injections of vitamin A were painful. </p> <p><b>Conclusions:</b> Whether clinicians decide to utilise repeat intramuscular doses of vitamin A to prevent chronic lung disease may depend upon the local incidence of this outcome and the value attached to achieving a modest reduction in the outcome balanced against the lack of other proven benefits and the acceptability of the treatment. Information on long‐term neurodevelopmental status suggests no evidence of either benefit or harm from the intervention. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000501-sec-0115" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000501-sec-0115"></div> <h3 class="title" id="CD000501-sec-0116">Implications for practice</h3> <section id="CD000501-sec-0116"> <p>Supplementing very low birth weight infants with vitamin A is associated with a small benefit in terms of reducing death or oxygen use at one month of age and a marginal reduction in oxygen use at 36 weeks' postmenstrual age. Supplementation with vitamin A may also reduce the incidence of retinopathy of prematurity and of nosocomial sepsis. The trials do not allow judgement as to the best route of supplementation, although the one trial that gave enteral vitamin A found no significant benefit for supplementation. One trial compared different intramuscular dosing regimens and the results suggest that, at least for infants with birth weight 401 to 1000 grams, the optimal dose appears to be 5000 IU three times weekly for four weeks, although on this regimen 26% of infants still had plasma vitamin A concentrations below 200 μg/L (0.70 μmol/L), which may indicate deficiency (<a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>). </p> <p>The conclusion of a marginal benefit at 36 weeks' postmenstrual age is derived from the results of five trials in which most infants had a birth weight less than 1000 grams. An earlier version of this Cochrane Review stated that whether clinicians decide to utilise repeat intramuscular doses of vitamin A may well depend upon the incidence of supplemental oxygen requirements at 36 weeks' postmenstrual age in extremely low birth weight infants in their unit; and their own assessment in conjunction with the review's findings of the benefits of a modest reduction in this outcome balanced against a lack of other proven benefits and the acceptability of the treatment (<a href="./references#CD000501-bbs2-0047" title="DarlowBA , GrahamPJ . Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD000501] ">Darlow 2002</a>). Long‐term follow‐up data at 18 to 22 months' corrected age of the largest included trial has shown no evidence of either benefit or harm at this time (<a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>). If a decision has been made not to treat for the early benefits the follow‐up study is unlikely to change that decision. On the other hand, if a decision has been made to treat for early benefits the follow‐up study is reassuring in that long‐term harmful effects are unlikely. </p> </section> <h3 class="title" id="CD000501-sec-0117">Implications for research</h3> <section id="CD000501-sec-0117"> <p>Further investigations are warranted as to the relationship between biochemical and functional vitamin A status in very low birth weight infants. Also, the benefits in terms of vitamin A status, clinical outcomes, safety, and acceptability to caretakers and parents of delivering vitamin A in an intravenous lipid emulsion from the first days of life, compared with delivery by intramuscular injections, should be investigated in a randomised controlled trial. </p> <p>There is an epidemic of retinopathy of prematurity in middle‐income and low‐income countries that affects many infants who are more mature at birth and have a greater birth weight than most infants who acquire severe retinopathy in more developed countries. In many of these countries the vitamin A status of both mothers and infants is particularly poor. The trends towards less retinopathy of prematurity associated with supplemental vitamin A and higher‐dose regimens seen in this review suggest that further trials should be undertaken in these countries to assess the possible contribution of poor perinatal vitamin A status to retinopathy of prematurity, and the need for intervention studies in these populations. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000501-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000501-sec-0036"></div> <div class="table" id="CD000501-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supplemental vitamin A compared to no supplementation in very low birth weight infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Supplemental vitamin A compared to no supplementation in very low birth weight infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> very low birth weight infants<br/> <b>Intervention:</b> supplemental vitamin A<br/> <b>Comparison:</b> no supplementation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> no supplementation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Supplemental vitamin A</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>168 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>144 per 1000<br/> (111 to 186) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86<br/> (0.66 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1165<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: 95% CI are wide and imprecise</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic lung disease (oxygen use at 28 days in survivors)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>725 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>674 per 1000<br/> (623 to 732) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93<br/> (0.86 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1070<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death or chronic lung disease (oxygen use at 28 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>798 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>742 per 1000<br/> (702 to 790) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93<br/> (0.88 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1165<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death before 36 weeks' postmenstrual age</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>168 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>168 per 1000<br/> (129 to 216) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00<br/> (0.77 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1089<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: 95% CI are wide and imprecise</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>546 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>486 per 1000<br/> (426 to 546) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.87<br/> (0.77 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>986<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death or chronic lung disease (oxygen use at 36 weeks' postmenstrual age)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>622 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>573 per 1000<br/> (523 to 629) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.92<br/> (0.84 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1089<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neurodevelopmental impairment at 18 to 22 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>481 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>428 per 1000<br/> (356 to 520) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.89<br/> (0.74 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>538<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Concerning imprecision: does not met the optimal information size criteria</i> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup><i>1</i> </sup><i>Imprecision: 95% CI are wide and imprecise</i> </p> <p><sup><i>2</i> </sup><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> <p><sup><i>3</i> </sup><i>Concerning imprecision; does not met the optimal information size criteria</i> </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000501-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000501-sec-0037"></div> <section id="CD000501-sec-0038"> <h3 class="title" id="CD000501-sec-0038">Description of the condition</h3> <p>Vitamin A is the generic name for a group of fat‐soluble compounds which have the biological activity of the primary alcohol retinol. Vitamin A is involved in the regulation and promotion of growth and differentiation of many cells and in maintaining the integrity of the epithelial cells of the respiratory tract. Vitamin A is also necessary for formation of the photosensitive visual pigment in the retina, reproductive functions, and immunocompetence. Carotenoids, dietary precursors of vitamin A, have antioxidant properties. </p> <p>The foetus accumulates vitamin A in the third trimester. The transport mechanism of vitamin A across the placenta and its regulation are not fully established. Premature infants have reduced hepatic stores of retinyl ester. In the plasma, vitamin A is bound to a specific carrier protein, retinol‐binding protein (RBP), and the resulting complex is further complexed with transthyretin (formerly pre‐albumin) (<a href="./references#CD000501-bbs2-0036" title="MactierH , WeaverLT . Vitamin A and preterm infants: what we know, what we don't know, and what we need to know. Archives of Disease in Childhood Fetal and Neonatal Edition2005;90(2):F103‐8. ">Mactier 2005</a>). Premature infants have lower concentrations of plasma RBP than term infants, and most preterm infants have low plasma vitamin A concentrations and low plasma retinol/RBP molar ratios, suggesting they are vitamin A deficient (<a href="./references#CD000501-bbs2-0042" title="ShenaiJP . Vitamin A. In: TsangRC , LucasA , UauyR , ZlotkinS editor(s). Nutritional Needs of the Preterm Infant: Scientific Basis and Practical Guidelines. Baltimore: Williams and Wilkins, 1993:87‐100. ">Shenai 1993</a>). Inadequate provision and delivery of vitamin A postnatally may exacerbate the problem. </p> </section> <section id="CD000501-sec-0039"> <h3 class="title" id="CD000501-sec-0039">Description of the intervention</h3> <p>Preterm infants who are unable to tolerate oral feeds are routinely fed parenterally with both an amino acid and dextrose mixture and a lipid emulsion. Multivitamin preparations containing retinol or an equivalent are commonly added to the amino acid and dextrose mixture and infused over 24 to 48 hours, but significant losses in delivered vitamin A have been shown to result from light degradation and from adsorption to the tubing. Alternatively, the multivitamins may be added to the lipid infusate (<a href="./references#CD000501-bbs2-0029" title="GreeneHL ,  PhillipsBL ,  FranckL ,  FillmoreCM ,  SaidHM ,  MurrellJE ,  etal . Persistently low retinol levels during and after parenteral feeding of very low birthweight infants; examination of losses into intravenous administration sets and a method of prevention by addition to a lipid emulsion. Pediatrics1987;79(6):894‐900. ">Greene 1987</a>). <a href="./references#CD000501-bbs2-0034" title="KennedyKA ,  StollBJ ,  EhrenkranzRA ,  OhW ,  WrightLL ,  StevensonDK ,  etal . Vitamin A to prevent bronchopulmonary dysplasia in very‐low‐birth‐weight infants: has the dose been too low? The NICHD Neonatal Research Network. Early Human Development1997;49(1):19‐31. ">Kennedy 1997</a> demonstrated improved serum retinol concentrations following intramuscular injections given three days per week. This route of administration has been adopted in several recent studies. In preterm infants who are able to tolerate enteral feeds, the absorption of enteral vitamin A by the immature gut may be poor. </p> <p>An 'adequate' concentration of plasma vitamin A in very low birth weight (VLBW) infants is not known. Concentrations below 200 μg/L (0.70 μmol/L) have been considered deficient in premature infants, and concentrations below 100 μg/L (0.35 μmol/L) indicate severe deficiency and depleted liver stores. Both the plasma RBP response (<a href="./references#CD000501-bbs2-0041" title="ShenaiJP ,  RushMG ,  StahlmanMT ,  ChytilF . Plasma retinol‐binding protein response to vitamin A administration in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1990;116(4):607‐14. ">Shenai 1990</a>) and the relative rise in serum retinal concentration (<a href="./references#CD000501-bbs2-0044" title="ZachmanRD ,  SamuelsDP ,  BrandJM ,  WinstonJF ,  PiJT . Use of the intramuscular relative‐dose‐response test to predict bronchopulmonary dysplasia in premature infants. American Journal of Clinical Nutrition1996;63(1):123‐9. ">Zachman 1996</a>) following intramuscular vitamin A administration have been described as useful tests to assess functional vitamin A status. However, in a recent review <a href="./references#CD000501-bbs2-0036" title="MactierH , WeaverLT . Vitamin A and preterm infants: what we know, what we don't know, and what we need to know. Archives of Disease in Childhood Fetal and Neonatal Edition2005;90(2):F103‐8. ">Mactier 2005</a> concluded that the relationship between measures of vitamin A concentration and functional vitamin A status is not clear in preterm infants. </p> <p>Vitamin A deficiency in laboratory animals produces a sequence of histopathological changes in the respiratory tract epithelium including necrotising tracheobronchiolitis and squamous metaplasia. These changes can be reversed by restoration of an adequate vitamin A status. Similar changes are observed in ventilated infants with chronic neonatal lung injury, leading to the suggestion that vitamin A deficiency may contribute to such injury and supplementation with vitamin A may facilitate healing and recovery (<a href="./references#CD000501-bbs2-0026" title="ChytilF . The lungs and vitamin A. American Journal of Physiology1992;262(5 Pt 1):L517‐27. ">Chytil 1992</a>; <a href="./references#CD000501-bbs2-0042" title="ShenaiJP . Vitamin A. In: TsangRC , LucasA , UauyR , ZlotkinS editor(s). Nutritional Needs of the Preterm Infant: Scientific Basis and Practical Guidelines. Baltimore: Williams and Wilkins, 1993:87‐100. ">Shenai 1993</a>). Two earlier studies reported that VLBW infants who developed chronic lung disease had lower concentrations of vitamin A than similar infants without chronic lung disease (<a href="./references#CD000501-bbs2-0033" title="HusteadVA , GutcherGR , AndersonSA , ZachmanRD . Relationship of vitamin A (retinol) status to lung disease in the preterm infant. Journal of Pediatrics1984;104(4):610‐5. ">Hustead 1984</a>; <a href="./references#CD000501-bbs2-0040" title="ShenaiJP , ChytilF , StahlmanMT . Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatric Research1985;19(2):185‐8. ">Shenai 1985</a>), although other studies from an era when all infants received more adequate supplementation have given conflicting results (<a href="./references#CD000501-bbs2-0025" title="ChabraS , ArnoldJD , LeslieGI , BowenJR , EarlJ , WoodF . Vitamin A status in preterm neonates with and without chronic lung disease. Journal of Paediatrics and Child Health1994;30(5):432‐5. ">Chabra 1994</a>; <a href="./references#CD000501-bbs2-0043" title="SpearsK , CheneyC , ZerzanJ . Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long‐term respiratory disability in very‐low‐birth‐weight infants. American Journal of Clinical Nutrition2004;80(6):1589‐94. ">Spears 2004</a>). </p> </section> <section id="CD000501-sec-0040"> <h3 class="title" id="CD000501-sec-0040">How the intervention might work</h3> <p>In the 1920s, vitamin A was considered to be an anti‐infective agent. There is increasing evidence that vitamin A does have a role in immune function (<a href="./references#CD000501-bbs2-0024" title="BatesCJ . Vitamin A. Lancet1995;345(8941):31‐5. ">Bates 1995</a>). Several studies in areas of the world where there is generally poor nutritional status have suggested vitamin A supplementation in infancy may be associated with decreased mortality and morbidity. In infants in Indonesia, <a href="./references#CD000501-bbs2-0032" title="HumphreyJH ,  AgoestinaT ,  WuL ,  UsmanA ,  NurachimM ,  SubardjaD ,  etal . Impact of neonatal vitamin A supplementation on infant morbidity and mortality. Journal of Pediatrics1996;128(4):489‐96. ">Humphrey 1996</a> reported that a single dose of 52 μmol (50,000 IU) given orally to term infants at birth reduced infant mortality and the prevalence of severe respiratory infections compared with placebo. A Cochrane review concluded that two oral doses of 200,000 IU in children under two years of age with measles was associated with a reduced risk of overall mortality and of pneumonia‐specific mortality (<a href="./references#CD000501-bbs2-0031" title="HuimingY , ChaominW , MengM . Vitamin A for treating measles in children. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD001479.pub3] ">Huiming 2005</a>). </p> <p>Vitamin A has a role early in gestation in the development of the cardiovascular system (<a href="./references#CD000501-bbs2-0036" title="MactierH , WeaverLT . Vitamin A and preterm infants: what we know, what we don't know, and what we need to know. Archives of Disease in Childhood Fetal and Neonatal Edition2005;90(2):F103‐8. ">Mactier 2005</a>). Animal models suggest higher vitamin A concentrations may accelerate postnatal constriction of the ductus arteriosus. The possibility that vitamin A supplementation may ameliorate other complications of prematurity, including retinopathy, intraventricular haemorrhage, and necrotising enterocolitis, has been suggested by a number of authors, although the basis for any effect is not clearly established. </p> <p>Vitamin A is potentially toxic and raised intracranial pressure and vomiting have been described in infants receiving large doses. In children and adults, chronic hypervitaminosis A may include bone and joint pain, mucocutaneous lesions, and hepatic dysfunction, but the syndrome has not been recognised in preterm infants. </p> </section> <section id="CD000501-sec-0041"> <h3 class="title" id="CD000501-sec-0041">Why it is important to do this review</h3> <p>Although a role for vitamin A in neonatal chronic lung disease is not in doubt, uncertainty exists regarding the efficacy of supplementation and whether additional benefit may be obtained by achieving concentrations beyond sufficiency. </p> <p>This is an update of previous versions of this Cochrane Review (<a href="./references#CD000501-bbs2-0045" title="DarlowBA , GrahamPJ . Vitamin A supplementation in very low birthweight infants. Cochrane Database of Systematic Reviews1998, Issue 4. [DOI: 10.1002/14651858.CD000501] ">Darlow 1998</a>; <a href="./references#CD000501-bbs2-0046" title="DarlowBA , GrahamPJ . Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000501] ">Darlow 2000</a>; <a href="./references#CD000501-bbs2-0047" title="DarlowBA , GrahamPJ . Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD000501] ">Darlow 2002</a>; <a href="./references#CD000501-bbs2-0048" title="DarlowBA , GrahamPJ . Vitamin A supplementation to prevent mortality and short and long‐term morbidity in very low birthweight infants. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD000501.pub2] ">Darlow 2007</a>; <a href="./references#CD000501-bbs2-0049" title="DarlowBA , GrahamPJ . Vitamin A supplementation to prevent mortality and short‐ and long‐term morbidity in very low birthweight infants. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD000501.pub3] ">Darlow 2011</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000501-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000501-sec-0042"></div> <p>To evaluate supplementation with vitamin A on the incidence of death or neonatal chronic lung disease and long‐term neurodevelopmental disability in very low birth weight (VLBW) infants compared with a control (placebo or no supplementation), and to consider the effect of the supplementation route, dose, and timing. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000501-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000501-sec-0043"></div> <section id="CD000501-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000501-sec-0045"> <h4 class="title">Types of studies</h4> <p>Randomised and quasi‐randomised controlled trials.</p> </section> <section id="CD000501-sec-0046"> <h4 class="title">Types of participants</h4> <p>Very low birth weight (VLBW) infants (defined as birth weight ≤ 1500 grams or less than 32 weeks' gestation). </p> </section> <section id="CD000501-sec-0047"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD000501-list-0001"> <li> <p>Vitamin A supplementation compared with control (placebo or no supplementation)</p> </li> <li> <p>Different vitamin A supplementation dosage regimens</p> </li> </ul> </p> </section> <section id="CD000501-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD000501-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD000501-list-0002"> <li> <p>Death (at 28 days and at hospital discharge)</p> </li> <li> <p>Chronic lung disease (defined as oxygen use at 28 days or at 36 weeks' postmenstrual age) </p> </li> <li> <p>Death or chronic lung disease (defined as oxygen use at 28 days or at 36 weeks' postmenstrual age) </p> </li> </ul> </p> </section> <section id="CD000501-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD000501-list-0003"> <li> <p>Vitamin A concentration (for studies comparing vitamin A dosage)</p> </li> <li> <p>Nosocomial infection</p> </li> <li> <p>Patent ductus arteriosus*</p> </li> <li> <p>Necrotising enterocolitis*</p> </li> <li> <p>Intraventricular haemorrhage (any intraventricular haemorrhage or severe intraventricular haemorrhage grades 3 and 4) (<a href="./references#CD000501-bbs2-0037" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics1978;92(4):529‐34. ">Papile 1978</a>)* </p> </li> <li> <p>Periventricular leukomalacia*</p> </li> <li> <p>Retinopathy of prematurity (any, or requiring laser therapy)**</p> </li> <li> <p>Neurodevelopment at 18 to 24 months</p> </li> <li> <p>Death at 18 to 24 months**</p> </li> <li> <p>Death or neurodevelopmental impairment at 18 to 24 months**</p> </li> <li> <p>Adverse effects, including manifestations of hypervitaminosis A, particularly raised intracranial pressure and mucocutaneous lesions </p> </li> </ul> </p> <p>*<i>Additional secondary outcomes added in the 2010 update</i> </p> <p>** <i>Additional secondary outcomes added in the 2016 update</i> </p> </section> </section> </section> <section id="CD000501-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <p>We used the criteria and standard methods of Cochrane and Cochrane Neonatal (see <a href="http://neonatal.cochrane.org/resources-review-authors" target="_blank">the Cochrane Neonatal Group search strategy for specialized register</a>). </p> <section id="CD000501-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We conducted a comprehensive search including: the Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i>, Issue 4, 2016; MEDLINE via PubMed (1966 to 1 May 2016); EMBASE (1980 to 1 May 2016); CINAHL (1982 to 1 May 2016). We used the following search terms: (vitamin A or retinol), plus database‐specific limiters for RCTs and neonates (see <a href="./appendices#CD000501-sec-0121">Appendix 1</a> for the full search strategies for each database). </p> <p>We applied no language restrictions. We searched the reference lists of any articles selected for inclusion in this review in order to identify additional relevant articles. </p> </section> <section id="CD000501-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We handsearched issues of paediatric and nutritional journals and abstracts from the Pediatric Academic Societies' Annual Meeting from 2002 to 2010. We also searched for conference abstracts from Pediatric Academic Societies (PAS) and the European Society for Paediatric Research (ESPR). Searches were carried out in Abstracts to View (2000 to 2014) and Pediatric Reseach. </p> <p>We searched clinical trials registries for ongoing or recently completed trials (<a href="https://www.clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; the World Health Organization’s International Trials Registry and Platform <a href="http://www.whoint/ictrp/search/en/" target="_blank">www.whoint/ictrp/search/en/</a>; and <a href="http://www.isrctn.com/" target="_blank">the ISRCTN Registry</a>) without date limits up to May 2016. </p> </section> </section> <section id="CD000501-sec-0054"> <h3 class="title" id="CD000501-sec-0054">Data collection and analysis</h3> <section id="CD000501-sec-0055"> <h4 class="title">Selection of studies</h4> <p>We included all trials fulfilling the review's selection criteria. We cited all identified articles and made the decision regarding inclusion or exclusion of the studies by consensus. In the event of disagreements, we sought the opinion of a third party (<a href="#CD000501-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD000501-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram: review update" data-id="CD000501-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> </div> </section> <section id="CD000501-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>For each included study, we collected information regarding the method of randomisation, blinding, drug intervention, stratification, trial location, and whether the trial was conducted at a single centre or multiple centres. We also collected information regarding inclusion criteria, including gestational age and postnatal age at the time of treatment. The list of data extraction fields for the trial interventions and outcomes are shown in <a href="./appendices#CD000501-sec-0122">Appendix 2</a>. </p> <p>We completed data collection sheets before comparing them and resolving any discrepancies by referring to the original sources. For each study, one review author entered the final and agreed data into <a href="./references#CD000501-bbs2-0038" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008. ">Review Manager 5</a> and a second review author checked the data. We referred to a third party to resolve any disagreements. </p> </section> <section id="CD000501-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For the 2010 and 2016 updates, one author assessed the risk of bias in the included studies according to the methods in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000501-bbs2-0030" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org,. ">Higgins 2011</a>). This built on the previous version's assessment of the methodological quality of the included studies. Any uncertainties were resolved through discussion with a second author. </p> <p>We assessed the following factors and judged them as having a high, low, or unclear risk of bias using the criteria in <a href="./references#CD000501-bbs2-0030" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org,. ">Higgins 2011</a>: </p> <p> <ul id="CD000501-list-0004"> <li> <p>Sequence generation (checking for possible selection bias)</p> </li> <li> <p>Allocation concealment (checking for possible selection bias)</p> </li> <li> <p>Blinding (checking for possible performance bias and detection bias)</p> </li> <li> <p>Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations) </p> </li> <li> <p>Selective outcome reporting (whether all of the study’s pre‐specified outcomes were reported (by checking the trial protocol if available) or whether the study failed to include results of a key outcome that would have been expected to have been reported) </p> </li> <li> <p>Other biases (including source of funding and sample size calculation)</p> </li> </ul> </p> <p>For each item, and where possible, we have provided a supporting quotation from the trial article. </p> </section> <section id="CD000501-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We conducted separate analyses for each of the following outcomes: neonatal death; chronic lung disease; retinopathy of prematurity; sepsis (one or more defined episodes); and neurodevelopmental disability. Since there were only a small numbers of deaths, we conducted analyses using the composite endpoints of neonatal chronic lung disease or death, and neurodevelopmental disability or death. All analyses were conducted on an intention‐to‐treat basis. We stratified the analyses by route of vitamin A administration. </p> <p>For dichotomous outcomes, we analysed the effect of vitamin A supplementation via both the risk ratio (RR) and the risk difference (RD) with 95% confidence intervals (CI). From 1/RD we calculated the number need to treat to benefit (NNTB) or the number needed to treat for an additional harmful outcome (NNTH). For vitamin A concentrations the intention was to focus the analysis on the mean difference between the supplemented and control groups. We combined continuous data using the standardised mean difference (SMD) and 95% CI. </p> </section> <section id="CD000501-sec-0059"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed between‐study heterogeneity using the standard Chi² test and the I² statistic.</p> </section> <section id="CD000501-sec-0060"> <h4 class="title">Data synthesis</h4> <p>We performed the meta‐analysis using <a href="./references#CD000501-bbs2-0038" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008. ">Review Manager 5</a>. We used the Mantel‐Haenszel method for estimates of the pooled RR and RD. For measured quantities we used the inverse variance method. We used the fixed‐effect model for all meta‐analyses. </p> <p>Pooled estimates of the effects and corresponding 95% confidence interval of the outcomes of neonatal death, chronic lung disease (oxygen use at 28 days in survivors), death or chronic lung disease (oxygen use at 28 days), death before 36 weeks' postmenstrual age, chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors) and neurodevelopmental disability at 18 to 22 months are included in the 'Summary of findings' tables in which the summary of the assessment of the evidence found for each outcome is presented. </p> <section id="CD000501-sec-0061"> <h5 class="title">Quality of evidence</h5> <p>For the 2016 update, we used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, as outlined in the GRADE Handbook (<a href="./references#CD000501-bbs2-0039" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editors. The GRADE Working Group. GRADE handbook for grading quality of evidence and strength of recommendations [Updated October 2013]. Available from www.guidelinedevelopment.org/handbook. ">Schünemann 2013</a>), to assess the quality of evidence for the following (clinically relevant) outcomes: neonatal death; chronic lung disease at 28 days and 36 weeks' postmenstrual age; death or chronic lung disease at 28 days and 36 weeks' postmenstrual age; and neurodevelopmental impairment at 18 to 22 months. </p> <p>Two authors independently assessed the quality of the evidence for each of the outcomes above. We considered evidence from randomised controlled trials as high quality but downgraded the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias); consistency across studies; directness of the evidence; precision of estimates; and presence of publication bias. We used the <a href="./references#CD000501-bbs2-0028" title="Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group. GRADEpro‐GDT. GRADE working group, 2013. ">GRADEpro‐GDT 2013</a> Guideline Development Tool to create a ‘Summary of findings’ table to report the quality of the evidence. </p> <p>The GRADE approach results in an assessment of the quality of a body of evidence in one of four grades: </p> <p> <ol id="CD000501-list-0005"> <li> <p>High: We are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate: We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low: Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low: We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ol> </p> </section> </section> <section id="CD000501-sec-0062"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If data were available, we planned subgroup analyses to address the effect of the route, dose, and timing of supplementation. </p> </section> <section id="CD000501-sec-0063"> <h4 class="title">Sensitivity analysis</h4> <p>Where appropriate, we planned sensitivity analyses to explore the impact of the risk of bias assessments. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000501-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000501-sec-0064"></div> <section id="CD000501-sec-0065"> <h3 class="title">Description of studies</h3> <section id="CD000501-sec-0066"> <h4 class="title">Results of the search</h4> <p>We identified 21 potentially relevant trials of which 11 met the eligibility criteria (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>; <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>; <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). Ten trials compared vitamin A with a control, while one trial compared three different vitamin A dosing regimens and had a primary outcome of serum retinol concentrations at 28 days (<a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>); see trial details in the '<a href="./references#CD000501-sec-0133" title="">Characteristics of included studies</a>' table. </p> <p>We excluded ten trials from the review (<a href="./references#CD000501-bbs2-0012" title="ArandaJV , AkramoffL , BeharryK , LingE , PapageorgiouA . Plasma concentrations of vitamin A and E during supplemental therapy in premature infants [abstract]. Pediatric Research1992;31:57A. ">Aranda 1992</a>; <a href="./references#CD000501-bbs2-0017" title="LandmanJ ,  SiveA ,  HeeseHD ,  Van der ElstC ,  SacksR . Comparison of enteral and intramuscular vitamin A supplementation in preterm infants. Early Human Development1992;30(2):163‐70. ">Landman 1992</a>; <a href="./references#CD000501-bbs2-0016" title="KooW , Krug‐WispeS , TsangR . Effect of differential enteral vitamin A intakes in very low birth weight infants [abstract]. Pediatric Research1993;33:306A. KooWW , Krug‐WispeS , SuccopP , TsangRC , NeylanM . Effect of different vitamin A intakes on very‐low‐birth‐weight infants. American Journal of Clinical Nutrition1995;62(6):1216‐20. ">Koo 1993</a>; <a href="./references#CD000501-bbs2-0019" title="RobbinsST , FletcherAB . Early vs delayed vitamin A supplementation in very‐low‐birth‐weight infants. Journal of Parenteral and Enteral Nutrition1993;17(3):220‐5. ">Robbins 1993</a>; <a href="./references#CD000501-bbs2-0020" title="RushMG ,  ShenaiJP ,  ParkerRA ,  ChytilF . Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates. Journal of Pediatrics1994;125(3):458‐62. ">Rush 1994</a>; <a href="./references#CD000501-bbs2-0014" title="CoutsoudisA , AdhikariM , PillayK , CoovadiaHM . Absorption of high‐dose enteral vitamin A in low‐birth‐weight neonates. South African Medical Journal1996;86(10 Suppl):1337‐9. ">Coutsoudis 1996</a>; <a href="./references#CD000501-bbs2-0015" title="CoutsoudisA , AdhikariM , PillayK , KuhnL , CoovadiaHM . Effect of vitamin A supplementation on morbidity of low‐birth‐weight neonates. South African Medical Journal2000;90(7):730‐6. ">Coutsoudis 2000</a>; <a href="./references#CD000501-bbs2-0013" title="AurvågAK ,  HenriksenC ,  DrevonCA ,  IversenPO ,  NakstadB . Improved vitamin A supplementation regimen for breastfed very low birth weight infant. Acta Pædiatrica2007;96(9):1296‐302. ">Aurvag 2007</a>; <a href="./references#CD000501-bbs2-0018" title="LongardtAC , SchmiedchenB , RailaJ , SchweigertFJ , ObladenM , BührerC , et al. Characterization of the vitamin A transport in preterm infants after repeated high‐dose vitamin A injections. European Journal of Clinical Nutrition2014;68(12):1300‐4. [PUBMED: 25315494] ">Longardt 2014</a>; <a href="./references#CD000501-bbs2-0021" title="SchmiedchenB , LongardtAC , LouiA , BührerC , RailaJ , SchweigertFJ . Effect of vitamin A supplementation on the urinary retinol excretion in very low birth weight infants. European Journal of Pediatrics2016;175(3):365‐72. [PUBMED: 26475348] ">Schmiedchen 2016</a>) (see '<a href="./references#CD000501-sec-0134" title="">Characteristics of excluded studies</a>'). <a href="./references#CD000501-bbs2-0019" title="RobbinsST , FletcherAB . Early vs delayed vitamin A supplementation in very‐low‐birth‐weight infants. Journal of Parenteral and Enteral Nutrition1993;17(3):220‐5. ">Robbins 1993</a> was not a randomised controlled trial. <a href="./references#CD000501-bbs2-0014" title="CoutsoudisA , AdhikariM , PillayK , CoovadiaHM . Absorption of high‐dose enteral vitamin A in low‐birth‐weight neonates. South African Medical Journal1996;86(10 Suppl):1337‐9. ">Coutsoudis 1996</a> and <a href="./references#CD000501-bbs2-0015" title="CoutsoudisA , AdhikariM , PillayK , KuhnL , CoovadiaHM . Effect of vitamin A supplementation on morbidity of low‐birth‐weight neonates. South African Medical Journal2000;90(7):730‐6. ">Coutsoudis 2000</a> enrolled low birth weight infants of less than 36 weeks' gestation and the primary outcome was the incidence of respiratory infections in the first year of life. <a href="./references#CD000501-bbs2-0013" title="AurvågAK ,  HenriksenC ,  DrevonCA ,  IversenPO ,  NakstadB . Improved vitamin A supplementation regimen for breastfed very low birth weight infant. Acta Pædiatrica2007;96(9):1296‐302. ">Aurvag 2007</a> compared vitamin A supplementation using human milk fortifier with historical controls and did not report clinical outcomes. Four studies were studies of pharmacodynamics that reported vitamin A concentrations but not clinical outcomes (<a href="./references#CD000501-bbs2-0012" title="ArandaJV , AkramoffL , BeharryK , LingE , PapageorgiouA . Plasma concentrations of vitamin A and E during supplemental therapy in premature infants [abstract]. Pediatric Research1992;31:57A. ">Aranda 1992</a>; <a href="./references#CD000501-bbs2-0017" title="LandmanJ ,  SiveA ,  HeeseHD ,  Van der ElstC ,  SacksR . Comparison of enteral and intramuscular vitamin A supplementation in preterm infants. Early Human Development1992;30(2):163‐70. ">Landman 1992</a>; <a href="./references#CD000501-bbs2-0016" title="KooW , Krug‐WispeS , TsangR . Effect of differential enteral vitamin A intakes in very low birth weight infants [abstract]. Pediatric Research1993;33:306A. KooWW , Krug‐WispeS , SuccopP , TsangRC , NeylanM . Effect of different vitamin A intakes on very‐low‐birth‐weight infants. American Journal of Clinical Nutrition1995;62(6):1216‐20. ">Koo 1993</a>; <a href="./references#CD000501-bbs2-0020" title="RushMG ,  ShenaiJP ,  ParkerRA ,  ChytilF . Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates. Journal of Pediatrics1994;125(3):458‐62. ">Rush 1994</a>). The unpublished study by <a href="./references#CD000501-bbs2-0012" title="ArandaJV , AkramoffL , BeharryK , LingE , PapageorgiouA . Plasma concentrations of vitamin A and E during supplemental therapy in premature infants [abstract]. Pediatric Research1992;31:57A. ">Aranda 1992</a> did not state the route of vitamin A supplementation and the reported vitamin A levels appeared to contain a decimal point error. <a href="./references#CD000501-bbs2-0017" title="LandmanJ ,  SiveA ,  HeeseHD ,  Van der ElstC ,  SacksR . Comparison of enteral and intramuscular vitamin A supplementation in preterm infants. Early Human Development1992;30(2):163‐70. ">Landman 1992</a> and <a href="./references#CD000501-bbs2-0020" title="RushMG ,  ShenaiJP ,  ParkerRA ,  ChytilF . Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates. Journal of Pediatrics1994;125(3):458‐62. ">Rush 1994</a> compared equivalent doses of vitamin A administered either enterally or intramuscularly. The data in <a href="./references#CD000501-bbs2-0020" title="RushMG ,  ShenaiJP ,  ParkerRA ,  ChytilF . Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates. Journal of Pediatrics1994;125(3):458‐62. ">Rush 1994</a> were only reported graphically. <a href="./references#CD000501-bbs2-0016" title="KooW , Krug‐WispeS , TsangR . Effect of differential enteral vitamin A intakes in very low birth weight infants [abstract]. Pediatric Research1993;33:306A. KooWW , Krug‐WispeS , SuccopP , TsangRC , NeylanM . Effect of different vitamin A intakes on very‐low‐birth‐weight infants. American Journal of Clinical Nutrition1995;62(6):1216‐20. ">Koo 1993</a> compared three doses of vitamin A added to preterm formula, which were given for an unstated period of time. </p> <p><a href="./references#CD000501-bbs2-0018" title="LongardtAC , SchmiedchenB , RailaJ , SchweigertFJ , ObladenM , BührerC , et al. Characterization of the vitamin A transport in preterm infants after repeated high‐dose vitamin A injections. European Journal of Clinical Nutrition2014;68(12):1300‐4. [PUBMED: 25315494] ">Longardt 2014</a> was not a randomised controlled trial and reported on serum retinol, retinyl palmitate, total retinol‐binding protein 4 (RBP4), retinol‐unbound RBP4 (apo‐RBP4) and transthyretin concentrations. Clinically relevant outcomes were not reported. </p> <p><a href="./references#CD000501-bbs2-0021" title="SchmiedchenB , LongardtAC , LouiA , BührerC , RailaJ , SchweigertFJ . Effect of vitamin A supplementation on the urinary retinol excretion in very low birth weight infants. European Journal of Pediatrics2016;175(3):365‐72. [PUBMED: 26475348] ">Schmiedchen 2016</a> studied the impact of urinary retinol excretion on the serum retinol concentration of 63 VLBW infants treated with vitamin A (5000 IU intramuscular, 3 times/week for 4 weeks) compared to 38 untreated infants classified as control group. The groups were not randomised. See trial details in the <a href="./references#CD000501-sec-0134" title="">Characteristics of excluded studies</a> table. </p> <p><a href="./references#CD000501-bbs2-0022" title="CalisiciE , YarciE , DegirmenciogluH , OncelMY , OguzSS , UrasN , et al. PO‐0731 The effects of early oral vitamin a treatment on the prevention of bronchopulmonary dysplasia in the low birth weight infants. Archives of Disease in Childhood2014;99(Suppl 2):A494. [DOI: 10.1136/archdischild‐2014‐307384.1371] ">Calisici 2014</a> is published only as an abstract and is awaiting further assessment. See trial details in the <a href="./references#CD000501-sec-0135" title="">Characteristics of studies awaiting classification</a> table. </p> </section> <section id="CD000501-sec-0067"> <h4 class="title">Trial location and size</h4> <p>Most trials were conducted in the USA (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>; <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>). Three trials were conducted in Europe: in Greece (<a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>); and the UK (<a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>). One trial was conducted in South Africa (<a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>); and one trial was conducted in Thailand (<a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). </p> <p>Most trials included fewer than 100 infants (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>; <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>; <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). Two included between 100 and 200 participants (<a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>); and one trial included 807 infants (<a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>). </p> </section> <section id="CD000501-sec-0068"> <h4 class="title">Participants</h4> <section id="CD000501-sec-0069"> <h5 class="title">Vitamin A versus control</h5> <p>The ten trials comparing vitamin A with a control reported outcomes for 1460 infants, 735 treated with vitamin A and 725 control infants. </p> <p><a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>: Single centre randomised controlled trial. Enrolled 40 infants, birth weight 700 to 1300 grams and gestational age 26 to 30 weeks, requiring supplemental oxygen and mechanical ventilation for at least 72 hours in the first week; Caucasian infants only; birth weight appropriate for gestational age; no congenital abnormalities. </p> <p><a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>: Single centre randomised controlled trial. Enrolled 55 infants with birth weight ≤ 1300 grams; gestation &lt; 29 weeks; requirement for &gt; 40% oxygen and mechanical ventilation for &gt; 72 hours in first week. </p> <p><a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>: Multicentre randomised controlled trial. Enrolled 49 infants with birth weight 700 to 1100 grams requiring supplemental oxygen and mechanical ventilation between 72 and 96 hours of age with previous cumulative duration of ventilation and oxygen &gt; 48 hours. Infants with growth restriction (undefined), congenital or chromosomal abnormalities, hydrops fetalis, congenital infection, neonatal hepatitis or 'do not resuscitate' order were excluded. </p> <p><a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>: Single centre randomised controlled trial. Enrolled 60 infants with birth weight between 1000 and 1500 grams; gestational age of ≤ 34 weeks; infants were receiving supplemental oxygen and mechanical ventilation for at least 72 hours during the first week; no congenital anomalies or infection; black South African infants. </p> <p><a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>: Single centre randomised controlled trial. Enrolled 86 infants with birth weight 725 to 1300 grams, age &lt; 96 hours; no intraventricular or periventricular haemorrhage, history of maternal substance abuse, or sexually transmitted disease; no congenital anomalies. </p> <p><a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>: Multicentre randomised controlled trial. Enrolled 807 infants with birth weight 401 to 1000 grams requiring supplemental oxygen or mechanical ventilation at 24 hours of age; and no major congenital anomalies, non‐bacterial infection, or terminal illness. </p> <p><a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>: Multicentre randomised controlled trial. Enrolled 154 infants with birth weight &lt; 1000 grams; no life‐threatening congenital abnormalities; consent before 24 hours of age. </p> <p><a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>: Single centre randomised controlled trial. Enrolled 40 infants with birth weight 500 to 1500 grams; gestation &lt; 32 weeks; having indwelling umbilical line; no major congenital malformations or chromosomal anomalies; and &lt; 24 hours of age. </p> <p><a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>: Double‐blind, randomised controlled trial conducted at three neonatal centres in Glasgow. Enrolled 89 infants (42 supplemented and 47 controls) &lt; 32 weeks' gestation or &lt; 1501 grams birth weight, or both. </p> <p>Supplemented infants received additional intramuscular vitamin A 10,000 IU 3 times weekly from day 2 for a minimum of 2 weeks or until establishment of oral feeding. </p> <p><a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>: Randomised controlled trial to assess the effect of vitamin A supplementation for prevention of bronchopulmonary dysplasia in VLBW premature infants. Eighty premature infants weighing &lt; 1500 grams who received mechanical ventilation or oxygen supplementation at 24 hours of age and admitted to Neonatal units of Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand. </p> </section> <section id="CD000501-sec-0070"> <h5 class="title">Vitamin A dosing regimens</h5> <p><a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>: Single centre randomised controlled trial evaluating vitamin A dosage. Enrolled 120 infants, birth weight between 401 and 1000 grams; requiring mechanical ventilation or supplemental oxygen at 24 hours of age; and no major congenital anomalies, non‐bacterial infection, or terminal illness. <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> used the same entry criteria as <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>. </p> </section> </section> <section id="CD000501-sec-0071"> <h4 class="title">Interventions</h4> <section id="CD000501-sec-0072"> <h5 class="title">Vitamin A versus control</h5> <p>Ten trials compared vitamin A with a control. All but <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a> and <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> gave supplemental vitamin A (water‐soluble retinyl palmitate) by intramuscular injection soon after birth, usually day four, and over the next 28 days. The trials varied in the vitamin A dose and regimen. </p> <p><a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>: Vitamin A (water‐soluble retinyl palmitate) versus control </p> <p>Supplemental 2000 IU vitamin A by intramuscular injection alternate days from day 4 for a total of 14 injections (n = 20) compared to normal saline placebo (n = 20) </p> <p>Other: both control and study infants received vitamin A 400 IU/dL in parenteral nutrition and 240 to 550 IU/dL from milk plus 1500 IU supplements when fed orally </p> <p><a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>: Vitamin A (water‐soluble retinyl palmitate) versus control </p> <p>Supplemental 4000 IU vitamin A intramuscular injection from day 4 to 6 on alternate days until extubated (n = 27) compared to normal saline placebo (n = 28). </p> <p><a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>: Vitamin A (water‐soluble retinyl palmitate) versus control </p> <p>Supplemental 2000 IU vitamin A by intramuscular injection alternate days from day 4 for 14 doses (n = 27) compared to normal saline placebo or mock injection (n = 22) </p> <p>Other: both control and study infants received 1200 to 1500 IU/d vitamin A in protein‐dextrose solution when on parenteral nutrition; when fed orally all infants received vitamin A 250 to 1030 IU/100 mL milk; antenatal steroids received by 26% infants in the vitamin A group and 41% in the control group; &gt; 90% received an artificial surfactant </p> <p><a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>: Vitamin A (water‐soluble retinyl palmitate) versus control </p> <p>Supplemental 4000 IU vitamin A intramuscular injection 3 times a week from day 4 for a total of 12 injections (n = 31); no supplementation (n = 29) </p> <p>Other: some control and study infants received vitamin A 1500 to 3000 IU after 1 week of age when fed orally </p> <p><a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>: Vitamin A (retinyl palmitate) versus control </p> <p>Supplemental vitamin A 80,000 RE/L (giving about 1300 to 3300 IU/kg/d) in intravenous lipid infused over 16 h from randomisation (48 to 96 hours) and while receiving parenteral nutrition (n = 44) compared to no supplementation (n = 42) </p> <p>Other: both control and study infants received vitamin A as multivitamin preparation added to protein‐dextrose solution (birth weight &lt; 1000 grams 1.5 mL/d, 210 RE/d; &gt; 1000 grams 3.4 mL/d, 476 RE/d) and oral supplements when fed orally </p> <p><a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>: Vitamin A (water‐soluble retinyl palmitate) versus control </p> <p>Supplemental 5000 IU vitamin A intramuscular injection 3 times a week for 4 weeks (n = 405) compared to sham injection (n = 402) </p> <p>Other: control and study infants received similar intakes of vitamin A from non‐study enteral and parenteral sources but amounts not stated; antenatal steroids received by 76% of infants in the vitamin A group and 74% in the control group; &gt; 80% received a natural surfactant </p> <p><a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>: Vitamin A (form not stated) versus control </p> <p>Supplemental 5000 IU vitamin A orally daily until day 28 (n = 77) compared to same volume look‐alike placebo liquid (n = 77) </p> <p>Other: control and study infants received 23 IU/kg/d vitamin A (stated amount but probably 233 IU) in intralipid when on parenteral nutrition; when on full enteral feeds and more than 14 days of age all infants received 5000 IU/kg/d vitamin A orally; antenatal steroids received by 77% in the vitamin A group and 82% in the control group; all but 1 infant in the control group received an artificial surfactant </p> <p><a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>: Vitamin A (water‐miscible preparation of vitamin A (Aquasol A)) versus control </p> <p>Supplemental 1500 to 3000 IU vitamin A (based on weight) by intramuscular injection on days 1, 3 and 7 (n = 22) compared to sham injection (n = 18) </p> <p>Other: most infants received parenteral nutrition including 466 IU/dL vitamin A and an additional 1000 IU supplement when fed orally; antenatal steroids received by 86% of infants in the vitamin A group and 72% in the control group </p> <p><a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>: Supplemented infants received additional intramuscular vitamin A 10,000 IU 3 times weekly from day 2 for a minimum of 2 weeks or until establishment of oral feeding. </p> <p><a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>: Infants were assigned to receive either intramuscular vitamin A 5000 IU 3 times/week (treatment group) or sham procedure (control group) for four weeks. </p> <p>Study and control infants were also administered standard vitamin A. However, the amount of vitamin A in standard therapy, and hence received by the control groups, varied between studies. When on parenteral nutrition infants in <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a> received vitamin A 400 IU/100 mL of protein‐dextrose infusion and usually less than 700 IU/kg/d from all sources. Infants in <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> received 1200 to 1500 IU/d of vitamin A in the protein‐dextrose solution. In <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>, infants on parenteral nutrition received no vitamin A but some received 1500 to 3000 IU/d after one week when fed orally. In <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>, the amount of standard vitamin A was not stated. In <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>, standard vitamin A was added to the protein‐dextrose solution, with infants less than 1000 grams receiving 700 IU/d and infants more than 1000 grams receiving 1580 IU/d. In <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>, infants received approximately 700 IU/kg/d in the first week, principally in protein‐dextrose solution, and closer to 1000 IU/kg/d in weeks two to four from all sources (data estimated from a graph). Infants in <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> were stated to receive 23 IU/kg/d added to intralipid when on parenteral nutrition (however, the standard UK dose at that time was 233 IU/kg/d and it was probable that infants in this study received this dose) and 5000 IU/kg/day orally when on full enteral feeds from the 14th postnatal day. In <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>, most infants on parenteral nutrition received 466 IU vitamin A added to 100 mL of the protein‐dextrose solution, and 1500 IU/d orally when fully enterally fed. In <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>, infants on parenteral nutrition received routine fat soluble vitamins as part of their lipid infusion (Vitlipid N). Lipid infusion was stopped once the infants had achieved 75% of their expected enteral intake and all infants received oral supplementation of vitamin A on day 14 of life if tolerating enteral feeds. </p> </section> <section id="CD000501-sec-0073"> <h5 class="title">Vitamin A dosing regimens</h5> <p><a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>: Infants were randomised to receive a standard vitamin A supplement by 5000 IU intramuscular injection of vitamin A on three days per week for four weeks (considered as the control group) (n=40), a higher dose of 10,000 IU on three days per week for four weeks (n = 40), or a once‐per‐week dose of 15,000 IU for four weeks (n = 40). </p> </section> </section> <section id="CD000501-sec-0074"> <h4 class="title">Outcomes</h4> <p>We contacted several trial authors for further details about the trial outcomes and data. <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a> gave complete data, published in an earlier abstract from 1990, and we sought and obtained further clarification from the trial authors concerning two outcomes: oxygen use at one month in survivors; and death or oxygen use at one month. We were able to update the data of <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> with information provided by the trial author to Dr K Kennedy at the time of an earlier review (<a href="./references#CD000501-bbs2-0034" title="KennedyKA ,  StollBJ ,  EhrenkranzRA ,  OhW ,  WrightLL ,  StevensonDK ,  etal . Vitamin A to prevent bronchopulmonary dysplasia in very‐low‐birth‐weight infants: has the dose been too low? The NICHD Neonatal Research Network. Early Human Development1997;49(1):19‐31. ">Kennedy 1997</a>). We obtained information on the age of infants at death from the corresponding author of <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>. Further information on the numbers examined for retinopathy of prematurity and numbers with any retinopathy in <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> were provided by the trial author. We also received further information on the timing of death, numbers of infants having serum retinol estimations at 28 days, and any retinopathy of prematurity from the author of <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a>. </p> <section id="CD000501-sec-0075"> <h5 class="title">Vitamin A versus control</h5> <p><a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>: Death before 31 days, bronchopulmonary dysplasia (oxygen requirement or ventilation at 31 days plus characteristic chest x‐ray), total days' oxygen, episodes of sepsis, retinopathy of prematurity, and vitamin A levels. </p> <p><a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>: Death before 31 days, bronchopulmonary dysplasia (oxygen requirement and characteristic chest x‐ray on day 31) and vitamin A levels. Unpublished data of <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> were available for 28, 29, 30 and 31 days. </p> <p><a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>: Death before 31 days, bronchopulmonary dysplasia (oxygen requirement at 31 days and characteristic chest x‐ray), oxygen requirement at 34 weeks' post‐conceptual age, retinopathy of prematurity, plasma vitamin A levels and retinyl binding protein at various times. </p> <p><a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>: Death before 31 days, bronchopulmonary dysplasia (oxygen or ventilation on day 31 and characteristic chest x‐ray; full data obtained from trial authors), culture‐proven sepsis, vitamin A levels at various times. </p> <p><a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>: Bronchopulmonary dysplasia (oxygen beyond 28 days and characteristic chest x‐ray, total days' oxygen requirement, vitamin A and retinol‐binding protein levels at various times. </p> <p><a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>: Oxygen requirement at, or death before, 36 weeks' postmenstrual age; oxygen requirement at, or death before, 28 days of age; culture‐proven sepsis; grade 3 or 4 intracranial haemorrhage; periventricular leukomalacia; vitamin A on study day 28 in subset of infants and relative dose‐response to 2000 IU vitamin A intramuscular. Examination for potential toxicity weekly. Assessment of neurodevelopmental status at 18 to 22 months' corrected age is available in Ambalavanan 2005 (companion paper for <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>). Additional subgroup analysis of 'small for gestational age' infants. </p> <p><a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>: Oxygen requirement at 28 days, death pre‐discharge, oxygen requirement at 36 weeks' postmenstrual age, retinopathy of prematurity requiring treatment. <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> also reported on a patent ductus arteriosus requiring treatment with indomethacin or surgical closure, but the timing of this was uncertain as to whether some infants had died before this outcome; hence we did not include these data. </p> <p><a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>: Failure of patent ductus arteriosus closure, defined as patent ductus arteriosus larger than trivial on day 14, indomethacin treatment, or surgical ligation. <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a> also reported deaths (and further information on the timing of these was obtained from the trial authors) and oxygen requirement at 36 weeks' postmenstrual age. </p> <p><a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>: Hepatic stores were assessed by relative dose response (RDR). The primary outcome measure was cone‐corrected dark‐adapted retinal rod sensitivity measured by electroretinogram at 36 weeks' postmenstrual age (PMA). Complications of prematurity were reported including use of respiratory support, intraventricular haemorrhage, retinopathy of prematurity, supplemental oxygen at 36 weeks' postmenstrual age, and death </p> <p><a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>: The investigators reported on serum vitamin A levels, and complications of prematurity including supplemental oxygen at 36 weeks postmenstrual age, duration of intubation, days on oxygen therapy, and length of hospital stay. </p> </section> <section id="CD000501-sec-0076"> <h5 class="title">Vitamin A dosing regimens</h5> <p>The primary outcome measure for the trial by <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> was serum retinol concentrations in μg/L at 28 days. <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> also reported on death before 36 weeks' postmenstrual age, oxygen requirement at or death before 36 weeks' postmenstrual age, and threshold retinopathy of prematurity. We obtained further information on timing of death, numbers of infants having serum retinol estimations, and any retinopathy of prematurity from the trial authors. </p> </section> </section> </section> <section id="CD000501-sec-0077"> <h3 class="title">Risk of bias in included studies</h3> <p>Full details of the 'Risk of bias' assessment are available by trial in the '<a href="#CD000501-sec-0057">Assessment of risk of bias in included studies</a>' tables and are summarised in <a href="#CD000501-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD000501-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000501-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD000501-sec-0078"> <h4 class="title">Allocation</h4> <p>Of the 11 included trials, eight used adequate methods to generate the allocation sequence and seven used adequate methods to conceal allocation (low risk of bias). <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> and <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a> did not provide details to allow this risk of bias component to be assessed, and <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a> provided details only for the sequence generation method (computer‐generated random numbers). </p> <p><a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> used shuffled blocks of sealed opaque envelopes for randomisation and stratified randomisation by birth weight. The randomisation and allocation for <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>, <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>, <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>, <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>, <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a> and <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> were conducted by someone outside of the trial team and used sealed envelopes. </p> </section> <section id="CD000501-sec-0079"> <h4 class="title">Blinding</h4> <p>Six trials blinded participants to the intervention and outcome assessors (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>, for example, used opaque tape to conceal the contents of the syringes and reported that the “staff responsible for patient care had no knowledge of group designation”. </p> </section> <section id="CD000501-sec-0080"> <h4 class="title">Incomplete outcome data</h4> <p>All but <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a> and <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> had complete follow‐up of participants. <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a> did not report outcomes on all infants entered into the study as they excluded 10 who transferred to another centre for surgery and two who died, for whom group assignment was not stated. For <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>, no information was available in the study abstract. </p> </section> <section id="CD000501-sec-0081"> <h4 class="title">Selective reporting</h4> <p>Most trials were free of selective reporting in that it was clear that all of the trial’s pre‐specified outcome measures and all expected outcome measures of interest to the review were reported. This was unclear for <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> because only a study abstract (from a conference proceedings) was available, while <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a> did not report all outcome measures of interest. </p> </section> <section id="CD000501-sec-0082"> <h4 class="title">Other potential sources of bias</h4> <p>This item was evaluated in relation to information about trial funding (such as industry funding) and sample size calculation. <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> appeared to be free of these sources of bias because the study protocol was described in detail, including the sample size calculation, and the trial was free of industry funding. <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a> was funded by the Chief Scientific Office, Scotland, and appeared to be free of other potential sources of bias. <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> and <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> were assessed as having a high risk of bias for this component: <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> because little information was available in the abstract; and <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> because few of the eligible infants were enrolled in the trial. Information about this item for the 'Risk of bias' assessment was unclear in the other studies. </p> </section> </section> <section id="CD000501-sec-0083"> <h3 class="title" id="CD000501-sec-0083">Effects of interventions</h3> <p>See: <a href="./full#CD000501-tbl-0001"><b>Summary of findings for the main comparison</b> Supplemental vitamin A compared to no supplementation in very low birth weight infants</a> </p> <section id="CD000501-sec-0084"> <h4 class="title">Comparison 1: Supplemental vitamin A versus no supplementation</h4> <section id="CD000501-sec-0085"> <h5 class="title">Neonatal death (Outcome 1.1)</h5> <p>Six trials reported on neonatal death (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>; <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>; <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>); none showed a significant difference between the vitamin A and control groups. The meta‐analysis does not support a reduction of the risk of neonatal death associated with receiving vitamin A (typical RR 0.86, 95% CI 0.66 to 1.11; typical RD −0.02, 95% CI −0.06 to 0.02; 1165 infants) (<a href="./references#CD000501-fig-0008" title="">Analysis 1.1</a>; <a href="#CD000501-fig-0003">Figure 3</a>).The quality of evidence for this outcome is moderate because of imprecision of estimates of effect (<a href="./full#CD000501-tbl-0001">summary of findings Table for the main comparison</a>). </p> <div class="figure" id="CD000501-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.1 Death (before 1 month)." data-id="CD000501-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.1 Death (before 1 month). </p> </div> </div> </div> </section> <section id="CD000501-sec-0086"> <h5 class="title">Chronic lung disease (oxygen use at 28 days in survivors) (Outcome 1.2)</h5> <p>Seven trials (the six trials above plus <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>) reported on chronic lung disease at 28 days. Only one study (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>) reported a statistically significant difference between intervention groups. The largest trial showed an important trend to no differences between treatment arms (RR 0.97, 95% CI 0.89 to 1.06; 718 infants) (<a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>). The meta‐analysis of these seven studies showed a trend towards a reduced risk of chronic lung disease between treatment arms (typical RR 0.93, 95% CI 0.86 to 1.01; typical RD −0.05, 95% CI −0.10 to 0.00; 1070 infants) (<a href="./references#CD000501-fig-0009" title="">Analysis 1.2</a>; <a href="#CD000501-fig-0004">Figure 4</a>). The overall quality of the evidence for this outcome was judged as moderate; we downgraded the quality of evidence based upon imprecision because although the 95% CI for the typical RR is narrow the result is consistent with minimal clnical effect. </p> <div class="figure" id="CD000501-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.2 Chronic lung disease (oxygen use at 28 days in survivors)." data-id="CD000501-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.2 Chronic lung disease (oxygen use at 28 days in survivors). </p> </div> </div> </div> </section> <section id="CD000501-sec-0087"> <h5 class="title">Death or chronic lung disease (oxygen use at 28 days) (Outcome 1.3)</h5> <p>Data for the combined outcome of death or chronic lung disease at 28 days were available in six trials (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>; <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>; <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>). Only one study reported a statistically significant difference in this outcome (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>). When the meta‐analysis was confined to the five trials reporting on supplementation via intramuscular injection (excluding <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>) there was a trend towards a reduction in death or oxygen use at one month that was of borderline statistical significance (typical RR 0.93, 95% CI 0.86 to 1.00; typical RD −0.06, 95% CI −0.11 to −0.00; NNTB 17, 95% CI 9 to 1000+; 1011 infants) (<a href="./references#CD000501-fig-0010" title="">Analysis 1.3</a>). When <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> (in which oral vitamin A supplementation was given to treated infants) was included in the meta‐analysis the pooled data showed a significant reduction in this outcome (typical RR 0.93, 95% CI 0.88 to 0.99; typical RD −0.05, 95% CI −0.10 to −0.01; NNTB 20, 95% CI 10 to 100; 1165 infants, I² = 37%) (<a href="./references#CD000501-fig-0010" title="">Analysis 1.3</a>; <a href="#CD000501-fig-0005">Figure 5</a>). The overall quality of the evidence for this outcome was judged as moderate; we downgraded the quality of evidence based upon imprecision because although the 95% CI for the typical RR is narrow the result is consistent with minimal clnical effect. </p> <div class="figure" id="CD000501-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.3 Death or chronic lung disease (oxygen use at 28 days)." data-id="CD000501-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.3 Death or chronic lung disease (oxygen use at 28 days). </p> </div> </div> </div> </section> <section id="CD000501-sec-0088"> <h5 class="title">Death (before 36 weeks' postmenstrual age) (Outcome 1.4)</h5> <p>Four trials reported on this outcome (<a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>). <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a> reported "death before discharge" (but not at 36 weeks' PMA) and therefore is not included in this analysis. The polled estimate of the effect showed no significant differences between the vitamin A and control groups (typical RR 1.00, 95% CI 0.77 to 1.29; 1089 infants) (<a href="./references#CD000501-fig-0011" title="">Analysis 1.4</a>; <a href="#CD000501-fig-0006">Figure 6</a>). The overall quality of the evidence for this outcome is moderate because of imprecision in estimates. </p> <div class="figure" id="CD000501-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.4 Death before 36 weeks' postmenstrual age." data-id="CD000501-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.4 Death before 36 weeks' postmenstrual age. </p> </div> </div> </div> </section> <section id="CD000501-sec-0089"> <h5 class="title">Chronic lung disease (oxygen use at 36 weeks' postmenstrual age) (Outcome 1.5)</h5> <p>Five trials reported on this outcome (<a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> reported a marginal reduction in oxygen use at 36 weeks postmenstrual age in the vitamin A group (RR 0.85, 95% CI 0.73 to 0.98; RD −0.09, 95% CI −0.16 to −0.01; NNTB 11, 95% CI 6 to 100; 693 infants). </p> <p>Similar results are seen in the pooled analysis, with a small beneficial effect of vitamin A on the risk of chronic lung disease at 36 weeks' postmenstrual age (typical RR 0.87, 95% CI 0.77 to 0.99; typical RD −0.07, 95% CI −0.13 to −0.01; NNTB 14, 95% CI 8 to 100; 986 infants) (<a href="./references#CD000501-fig-0012" title="">Analysis 1.5</a>; <a href="#CD000501-fig-0007">Figure 7</a>). The overall quality of the evidence for this outcome was judged as moderate; we downgraded the quality of evidence based upon imprecision because although the 95% CI for the typical RR is narrow the result is consistent with minimal clnical effect. </p> <div class="figure" id="CD000501-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.5 Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors)." data-id="CD000501-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.5 Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors). </p> </div> </div> </div> </section> <section id="CD000501-sec-0090"> <h5 class="title">Death or chronic lung disease (Oxygen use at 36 weeks' postmenstrual age) (Outcome 1.6) </h5> <p>Four trials reported on this outcome (<a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>). <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> showed a trend towards reduction in death or chronic lung disease in the vitamin A group that was of borderline statistical significance (RR 0.89, 95% CI 0.79 to 1.00; RD −0.07, 95% CI −0.14 to 0.00). Pooling the data from the four trials did not meaningfully alter this finding (typical RR 0.92, 95% CI 0.84 to 1.01; typical RD −0.05, 95% CI −0.11 to 0.01; 1089 infants) (<a href="./references#CD000501-fig-0013" title="">Analysis 1.6</a>). Including the outcome data at 34 weeks' postmenstrual age from <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> in this analysis, there was essentially no difference to these results. The overall quality of the evidence for this outcome was judged as moderate; we downgraded the quality of evidence based upon imprecision because although the 95% CI for the typical RR is narrow the result is consistent with minimal clnical effect. </p> </section> <section id="CD000501-sec-0091"> <h5 class="title">Death (at 18 to 24 months) (Outcome 1.7)</h5> <p><a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> reported on this outcome and found no significant difference between the vitamin A and control groups (RR 0.95, 95% CI 0.71 to 1.27; RD −0.01, 95% CI −0.06 to 0.04; 807 infants (<a href="./references#CD000501-fig-0014" title="">Analysis 1.7</a>). </p> </section> <section id="CD000501-sec-0092"> <h5 class="title">Neurodevelopmental impairment at 18 to 24 months (Outcome 1.8)</h5> <p>Ambalavanan 2005 followed up 88% of the surviving infants who participated in the <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> trial at 18 to 22 months corrected age. Forty‐one infants could not be assessed, leaving 290 infants in the intervention group and 289 in the control group (15% lost to follow‐up in both groups). There was no difference between the groups in either neurodevelopment impairment, defined as one or more of: Bayley II Mental Index less than 70, Psychomotor Index less than 70, any cerebral palsy, blind in both eyes, or bilateral hearing aids (RR 0.89, 95% CI 0.74 to 1.08; RD −0.05, 95% CI −0.04 to 0.03; 1538 infants) (<a href="./references#CD000501-fig-0015" title="">Analysis 1.8</a>). The overall quality of the evidence for this outcome is moderate because of imprecision in estimates. </p> </section> <section id="CD000501-sec-0093"> <h5 class="title">Death or neurodevelopmental impairment at 18 to 24 months (Outcome 1.9)</h5> <p><a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> reported on this outcome and found no significant differences between the vitamin A and control groups (RR 0.92, 95% CI 0.81 to 1.05; RD −0.05, 95% CI −0.12 to 0.03; 687 infants) (<a href="./references#CD000501-fig-0016" title="">Analysis 1.9</a>). </p> </section> <section id="CD000501-sec-0094"> <h5 class="title">Patent ductus arteriosus (Outcome 1.10)</h5> <p><a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a> found no significant difference in the failure of ductal closure or treatment by day 14 between the vitamin A and control groups (RR 0.98, 95% CI 0.56 to 1.72; RD −0.01, 95% CI −0.32 to 0.30; 40 infants) (<a href="./references#CD000501-fig-0017" title="">Analysis 1.10</a>). </p> <p><a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a> reported on any evidence of PDA diagnosed by echocardiography but did not report rates of treatment between the two groups. </p> </section> <section id="CD000501-sec-0095"> <h5 class="title">Sepsis (Outcome 1.11)</h5> <p>Three trials reported on one or more episodes of culture‐proven nosocomial sepsis (<a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). The pooled data showed a non‐significant trend towards a reduction in sepsis in the vitamin A group (typical RR 0.89, 95% CI 0.76 to 1.04; typical RD −0.05, 95% CI −0.11 to 0.01; 947 infants) (<a href="./references#CD000501-fig-0018" title="">Analysis 1.11</a>). </p> </section> <section id="CD000501-sec-0096"> <h5 class="title">Necrotising enterocolitis (Outcome 1.12)</h5> <p>Four trials reported on necrotising enterocolitis (<a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>); and the pooled data showed no significant difference between the vitamin A and control groups (typical RR 0.92, 95% CI 0.67 to 1.27; typical RD −0.01, 95% CI −0.05 to 0.03; 1101 infants) (<a href="./references#CD000501-fig-0019" title="">Analysis 1.12</a>). </p> </section> <section id="CD000501-sec-0097"> <h5 class="title">Intraventricular haemorrhage (Outcome 1.13)</h5> <p>Three trials reported on any intraventricular haemorrhage (<a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>). The pooled data found no significant difference between the vitamin A and control groups (typical RR 0.95, 95% CI 0.82 to 1.10; typical RD −0.02, 95% CI −0.09 to 0.04; 907 infants) (<a href="./references#CD000501-fig-0020" title="">Analysis 1.13</a>). </p> <p>Four of the trials also reported on severe intraventricular haemorrhage (<a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). There was no significant difference between the vitamin A and control groups (typical RR 0.95, 95% CI 0.72 to 1.25; typical RD −0.01, 95% CI −0.05 to 0.04; 1035 infants) (<a href="./references#CD000501-fig-0020" title="">Analysis 1.13</a>). </p> </section> <section id="CD000501-sec-0098"> <h5 class="title">Periventricular leukomalacia (Outcome 1.14)</h5> <p><a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> reported on this outcome and found no significant differences in periventricular leukomalacia between the vitamin A and control groups (RR 0.74, 95% CI 0.44 to 1.25; RD −0.01, 95% CI −0.05 to 0.03; 646 infants) (<a href="./references#CD000501-fig-0021" title="">Analysis 1.14</a>). </p> </section> <section id="CD000501-sec-0099"> <h5 class="title">Retinopathy of prematurity (Outcome 1.15)</h5> <p>Three trials reported on this outcome (<a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>; <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a>). Additional data was obtained from the trial author of <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>. <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a> and <a href="./references#CD000501-bbs2-0003" title="KiatchoosakunP , JirapraditthaJ , PanthongviriyakulMC , KhampitakT , YongvanitP , BoonsiriP . Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very‐low‐birth‐weight premature Thai infants: a randomized trial. Journal of the Medical Association of Thailand2014;97(Suppl 10):S82‐8. [PUBMED: 25816542] ">Kiatchoosakun 2014</a> noted a trend to reduced incidence of retinopathy of prematurity in the vitamin A group; this was reflected in the pooled trial data (typical RR 0.81, 95% CI 0.65 to 1.01; typical RD −0.10, 95% CI −0.20 to 0.00; 255 infants)(<a href="./references#CD000501-fig-0022" title="">Analysis 1.15</a>). </p> </section> <section id="CD000501-sec-0100"> <h5 class="title">Retinopathy of prematurity requiring laser therapy (Outcome 1.16)</h5> <p>Two trials reported on retinopathy of prematurity requiring laser therapy (<a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>). No difference was seen in the risk of retinopathy of prematurity requiring laser therapy (typical RR 1.27, 95% CI 0.55, 2.94; 236 infants). </p> </section> <section id="CD000501-sec-0101"> <h5 class="title">Adverse effects</h5> <p>The studies by <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>, <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a>, and <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a> make no comment on monitoring for adverse effects. <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a> noted that clinical monitoring for toxicity included periodic anterior fontanelle pressure assessment to detect raised intracranial pressure and reported no clinical or biochemical evidence of toxicity. <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> reported that intramuscular injections of vitamin A were painful, and both this trial and <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a> found no evidence of biochemical toxicity. <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> noted that the incidence of potential adverse effects, seizures, and persistent vomiting did not differ between the groups. Infants in <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> were independently assessed for signs of toxicity on a weekly basis; a suspected or definite increase in fontanelle tension was slightly more frequent in control than supplemented infants (18% versus 15%, P = 0.26), and potential toxicity unexplained by other factors occurred in 0.8% controls and 1.0% supplemented infants. </p> </section> </section> <section id="CD000501-sec-0102"> <h4 class="title">Vitamin A dosing regimens</h4> </section> <section id="CD000501-sec-0103"> <h4 class="title">Comparison 2: Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 <i>×</i> week for 4 weeks </h4> </section> <section id="CD000501-sec-0104"> <h4 class="title">Comparison 3: Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks </h4> <p><a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> compared a 'standard' intramuscular regimen of supplemental vitamin A (5000 IU 3 × per week for 4 weeks) as used in <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>, with a higher dose (10,000 IU 3 × per week for 4 weeks) and with a once‐per‐week dose (15,000 IU weekly for 4 weeks). The vitamin A was given intramuscularly, and the trial's primary outcome was the serum retinol concentration at 28 days </p> <section id="CD000501-sec-0105"> <h5 class="title">Death before 36 weeks' postmenstrual age (Outcomes 2.1 and 3.1)</h5> <p>There was no significant difference for this outcome between the higher‐ and standard‐dose groups (80 infants) (<a href="./references#CD000501-fig-0024" title="">Analysis 2.1</a>), or between the once‐a‐week and standard regimens (80 infants) (<a href="./references#CD000501-fig-0033" title="">Analysis 3.1</a>). </p> </section> <section id="CD000501-sec-0106"> <h5 class="title">Oxygen use at 36 weeks' postmenstrual age in survivors (Outcomes 2.2 and 3.2)</h5> <p>There was no significant difference for this outcome between the higher‐ and standard‐dose groups (61 infants) (<a href="./references#CD000501-fig-0025" title="">Analysis 2.2</a>), or between the once‐a‐week and standard regimens (61 infants, <a href="./references#CD000501-fig-0034" title="">Analysis 3.2</a>). </p> </section> <section id="CD000501-sec-0107"> <h5 class="title">Death or oxygen use at 36 weeks' postmenstrual age (Outcomes 2.3 and 3.3)</h5> <p>There was no significant difference for this outcome between the higher‐ and standard‐dose groups (80 infants) (<a href="./references#CD000501-fig-0026" title="">Analysis 2.3</a>), or between the once‐a‐week and standard regimens (80 infants, <a href="./references#CD000501-fig-0035" title="">Analysis 3.3</a>). </p> </section> <section id="CD000501-sec-0108"> <h5 class="title">Vitamin A concentration (retinol) (Outcomes 2.4, 2.5, 3.4 and 3.5)</h5> <p>There was no significant difference between the standard dose and higher dose for this outcome when measured as retinol (μg/L) on study day 28 (55 infants) (<a href="./references#CD000501-fig-0027" title="">Analysis 2.4</a>) or as retinol (&lt; 200 μg/L) on day 28 (%) (55 infants) (<a href="./references#CD000501-fig-0028" title="">Analysis 2.5</a>). </p> <p>The once‐per‐week regimen resulted in significantly lower concentrations than the standard regimen on study day 28 (SMD −0.97, 95% CI ‐1.56 to −0.38; 50 infants (<a href="./references#CD000501-fig-0036" title="">Analysis 3.4</a>). The once‐per‐week dose regimen also resulted in a higher proportion of infants with 28‐day retinol concentrations below 200 μg/L (RR 2.52, 95% CI 1.24 to 5.09; 50 infants) (<a href="./references#CD000501-fig-0037" title="">Analysis 3.5</a>) </p> </section> <section id="CD000501-sec-0109"> <h5 class="title">Necrotising enterocolitis (Outcome 2.6 and 3.6)</h5> <p>There were no significant differences for this outcome between the higher‐ and standard‐dose groups (80 infants) (<a href="./references#CD000501-fig-0029" title="">Analysis 2.6</a>) or between the once‐a‐week and standard regimens (80 infants) (<a href="./references#CD000501-fig-0038" title="">Analysis 3.6</a>). </p> </section> <section id="CD000501-sec-0110"> <h5 class="title">Retinopathy of prematurity (Outcomes 2.7, 2.8, 3.7 and 3.8)</h5> <p>There was a trend to fewer infants with retinopathy of prematurity in the higher‐dose group compared to the standard‐dose group, for both any grade (63 infants)(<a href="./references#CD000501-fig-0030" title="">Analysis 2.7</a>) and threshold disease (63 infants)(<a href="./references#CD000501-fig-0031" title="">Analysis 2.8</a>). </p> <p>When we compared the once‐a‐week regimen with the standard regimen there was a trend to fewer infants with retinopathy of prematurity for any grade (64 infants) (<a href="./references#CD000501-fig-0039" title="">Analysis 3.7</a>) but there was no significant difference between the groups when measured as threshold disease (64 infants) (<a href="./references#CD000501-fig-0040" title="">Analysis 3.8</a>). </p> <p>For both analyses, only small numbers of infants were involved and the trial lacked power to assess this outcome. </p> </section> <section id="CD000501-sec-0111"> <h5 class="title">Sepsis (Outcomes 2.9 and 3.9)</h5> <p>There were no significant differences in the number of episodes of sepsis between the higher‐ and standard‐dose groups (80 infants) (<a href="./references#CD000501-fig-0032" title="">Analysis 2.9</a>) or between the once‐a‐week and standard regimens (80 infants) (<a href="./references#CD000501-fig-0041" title="">Analysis 3.9</a>). </p> </section> <section id="CD000501-sec-0112"> <h5 class="title">Vitamin A concentration</h5> <p>The data did not allow a quantitative analysis of vitamin A concentrations among survivors.</p> </section> <section id="CD000501-sec-0113"> <h5 class="title">Adverse effects</h5> <p><a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> monitored for potential adverse effects. One infant in the higher‐dose group was noted to have transient fullness of the anterior fontanelle without other causes and which resolved in 48 hours. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000501-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000501-sec-0114"></div> <p>This Cochrane review includes 11 randomised controlled trials, ten comparing vitamin A with placebo and one comparing different vitamin A regimens. <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> is the largest trial included in the review with a sample size (807 infants) more than five times that of the next largest trial (154 infants, <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>). </p> <p>The first version of this review reported a significant reduction in death or oxygen use at one month of age in vitamin A‐treated infants (RR 0.75, 95% CI 0.62 to 0.91) (<a href="./references#CD000501-bbs2-0045" title="DarlowBA , GrahamPJ . Vitamin A supplementation in very low birthweight infants. Cochrane Database of Systematic Reviews1998, Issue 4. [DOI: 10.1002/14651858.CD000501] ">Darlow 1998</a>). The addition of <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>, which found no difference in outcome at one month, to the pooled data resulted in the meta‐analysis showing only a trend of borderline significance towards reduction in death or oxygen use at this time (RR 0.93, 95% CI 0.86 to 1.00) (<a href="./references#CD000501-bbs2-0046" title="DarlowBA , GrahamPJ . Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000501] ">Darlow 2000</a>). <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>, the only trial to give supplemental vitamin A via the enteral route, had a moderate sample size (154) and found no significant benefit of supplementation; however, the further addition of data from this trial resulted in the meta‐analysis showing a small but statistically significant reduction in this outcome (RR 0.93, 95% CI 0.88 to 0.99; RD −0.05, 95% CI −0.10 to −0.01; NNTB 20, 95% CI 10 to 100). </p> <p>Four trials which gave intramuscular vitamin A to supplemented infants reported outcomes at 36 weeks' postmenstrual age (<a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>; <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>; <a href="./references#CD000501-bbs2-0004" title="MactierH , McCullochDL , HamiltonR , GallowayP , BradnamMS , YoungD , et al. Vitamin A supplementation improves retinal function in infants at risk of retinopathy of prematurity. Journal of Pediatrics2012;160(6):954‐9. ">Mactier 2012</a>). The meta‐analysis of these trials supports a marginal reduction in oxygen use in vitamin A‐treated infants at 36 weeks' postmenstrual age (typical RR 0.89, 95% CI 0.78 to 1.00; typical RD −0.06, 95% CI −0.13 to 0.00; NNTB 16, 95% CI 8 to 1000+; 906 infants) as well as a marginal reduction in death or oxygen use at 36 weeks' postmenstrual age (typical RR 0.92, 95% CI 0.84 to 1.01; typical RD −0.05, 95% CI −0.11 to 0.01; 1089 infants). From the meta‐analysis of the combined data, the NNTB with regard to oxygen requirement at 36 weeks is 13 with wide 95% confidence intervals, ranging from 7 to more than 1000. It is also noteworthy that there was no difference in other outcomes, including days of ventilation and length of stay, and between vitamin A‐supplemented and control infants in <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>. </p> <p>Some differences between the trials may be explained by the differences in patient populations (birth weight and ethnicity), the differences in both the route of vitamin A supplementation (intramuscular, intravenous in lipid emulsion, or enteral), and the dose given. <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> and <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> included somewhat lower birth weight infants (401 to 1000 grams and &lt; 1000 grams respectively) than most other trials whereas other trials used various lower weight limits (500 grams for <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a>; 700 grams for <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> and <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a>; 725 grams for <a href="./references#CD000501-bbs2-0011" title="WerkmanSH ,  PeeplesJM ,  CookeRJ ,  TolleyEA ,  CarlsonSE . Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. American Journal of Clinical Nutriton1994;59(3):586‐92. ">Werkman 1994</a>; and 1000 grams for <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>). The incidence of supplemental oxygen requirement at one month of age in vitamin A‐supplemented infants was higher at 73% in <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> and 83% in <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>, compared with a range of 34% to 67% in the other trials; this is consistent with their lower birth weight and gestational age. For the smallest infants the outcome at 36 weeks' postmenstrual age may be more clinically relevant. </p> <p>In all the included trials there were higher vitamin A or retinol concentrations in the infants in the vitamin A group compared with the control group at most of the time periods studied. <a href="./references#CD000501-bbs2-0034" title="KennedyKA ,  StollBJ ,  EhrenkranzRA ,  OhW ,  WrightLL ,  StevensonDK ,  etal . Vitamin A to prevent bronchopulmonary dysplasia in very‐low‐birth‐weight infants: has the dose been too low? The NICHD Neonatal Research Network. Early Human Development1997;49(1):19‐31. ">Kennedy 1997</a> reported that an intramuscular dose of 5000 IU vitamin A three times per week was required to achieve serum concentrations greater than 250 μg/L in most very low birth weight infants. This was the dose used by <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> and was generally greater than the dose used in earlier studies; for example, <a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a> used 4000 IU three times weekly, <a href="./references#CD000501-bbs2-0005" title="PapagaroufalisC , CairisM , PantazatouE , MeghreliCh , XanthouM . A trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia [abstract]. Pediatric Research1988;23:518A. ">Papagaroufalis 1988</a> used 4000 IU on alternate days while the infants were ventilated, <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> and <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a> used 2000 IU on alternate days, and <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a> used between 1500 IU and 3000 IU for three doses only. Nevertheless, in <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> 25% of infants who received supplemental vitamin A and 54% of controls (data from the first 300 enrolled infants) had vitamin A concentrations below 200 μg/L on day 28. Similar percentages, 22% of those who received supplemental vitamin A and 45% of controls, had a relative dose response (change in the serum retinol concentration divided by the pre‐injection concentration) of more than 10% following an intramuscular dose of 2000 IU. Taken together, these data suggest that an even higher dose of vitamin A given intramuscularly may be required to achieve vitamin A sufficiency in very premature infants. </p> <p>In <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>, infants received a much higher cumulative dose of supplemental vitamin A than in other studies (140,000 IU in 28 days compared with 60,000 IU in <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>) but by the enteral route. Vitamin A concentrations were only measured in the first 84 infants enrolled and the median concentration 24 hours after the first dose was significantly higher in supplemented infants (230 μg/L versus 150 μg/L). At 7 and 28 days of age, however, there were no significant differences in vitamin A concentrations between the groups and the median concentration in both groups was less than 200 μg/L at these times. Vitamin A absorption is less efficient using the enteral route. <a href="./references#CD000501-bbs2-0020" title="RushMG ,  ShenaiJP ,  ParkerRA ,  ChytilF . Intramuscular versus enteral vitamin A supplementation in very low birth weight neonates. Journal of Pediatrics1994;125(3):458‐62. ">Rush 1994</a> compared the same dose of vitamin A (2000 IU/kg on alternate days) given by intramuscular injection or orally and reported that the former route gave higher plasma vitamin A concentrations after one week. <a href="./references#CD000501-bbs2-0017" title="LandmanJ ,  SiveA ,  HeeseHD ,  Van der ElstC ,  SacksR . Comparison of enteral and intramuscular vitamin A supplementation in preterm infants. Early Human Development1992;30(2):163‐70. ">Landman 1992</a> reported that enteral supplementation with 5000 IU vitamin A daily resulted in similar plasma concentrations at 32 days of age to those resulting from 2000 IU vitamin A on alternate days by the intramuscular route. </p> <p>There were also quite marked differences in the vitamin A dose received by the control groups. This has previously been suggested to account for differences in outcome between the early studies (<a href="./references#CD000501-bbs2-0035" title="LorchV , GaylordMS . Vitamin A and bronchopulmonary dysplasia. Journal of Pediatrics1994;124(2):328‐9. ">Lorch 1994</a>). Infants in the control group in <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> received higher doses of vitamin A and had mean vitamin A concentrations at weeks three and four of greater than 200 μg/L. This is higher than in infants in the control group in <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a> in which mean vitamin A concentrations were less than 150 μg/L at these times. One interpretation is that <a href="./references#CD000501-bbs2-0008" title="ShenaiJP ,  KennedyKA ,  ChytilF ,  StahlmanMT . Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. Journal of Pediatrics1987;111(2):269‐77. ">Shenai 1987</a> demonstrated a benefit of supplemental vitamin A in a population with vitamin deficiency, while <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> showed a minimal benefit of additional supplementation in a population with more adequate vitamin status. However, <a href="./references#CD000501-bbs2-0027" title="GeorgieffMK ,  MammelMC ,  MillsMM ,  GunterEW ,  JohnsonDE ,  ThompsonTR . Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise. Journal of Pediatrics1989;114(2):301‐4. ">Georgieff 1989</a> reported that postnatal steroids led to a near doubling of plasma vitamin A concentrations, and this finding was confirmed in <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>. Certainly variability in exposure to postnatal steroids complicates the interpretation of these data. Two trials included in this review reported the incidence of treatment with postnatal steroids (<a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a>, 46% in vitamin A group and 44% in controls; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a>, 39% and 34% respectively), while two others noted that steroids were used in some infants (<a href="./references#CD000501-bbs2-0002" title="BentalRY , CooperPA , CumminsRR , SandlerDL , WainerS , RotschildA . Vitamin A therapy ‐ effects on the incidence of bronchopulmonary dysplasia. South African Journal of Food Science and Nutrition1994;6(4):141‐5. BentalRY , CooperPA , SandlerD , WainerS . The effects of vitamin A therapy on the incidence of chronic lung disease in premature infants [abstract]. Pediatric Research1990;25:296A. ">Bental 1994</a>; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>). </p> <p>Further information on the optimal dosage of intramuscular vitamin A for infants with birth weights 401 to 1000 grams is available from the <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> trial. <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> compared the dose regimen used by <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> (5000 IU three times weekly for four weeks) with both a higher dose (10,000 IU three times weekly for four weeks) and a once‐a‐week dose (15,000 IU weekly for four weeks) in 120 infants. Only two infants received postnatal steroids between study days 21 and 28. Compared with the standard regimen, the higher dose regimen was not associated with a significantly higher mean retinol concentration at 28 days and there were no differences between the groups in the proportion of infants having concentrations of less than 200 μg/L at this time (26% versus 21%). The once‐a‐day regimen, however, was associated with significantly lower mean concentrations at 28 days and increased the risk of infants having concentrations of less than 200 μg/L at this time by a factor of 2.5 (26% versus 65%). </p> <p>Many other variables will also affect the rate of chronic lung disease, which is known to vary considerably between centres. These factors include use of antenatal steroids (stated in four trials: <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> where they were received by 26% of study infants and 41% controls; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> where the rates were 76% and 74%; <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> where the rates were 77% and 82%; and <a href="./references#CD000501-bbs2-0007" title="NafdayS , RavishankarC , GreenRS , KamenirSA , LorberR , Stacewicz‐SapuntzakisM , et al. A trial of vitamin A therapy to facilitate ductal closure in premature infants [abstract]. Pediatric Research2002;51:308A. RavishankarC ,  NafdayS ,  GreenRS ,  KamenirS ,  LorberR ,  Stacewicz‐SapuntzakisM ,  etal . A trial of vitamin A therapy to facilitate ductal closure in premature infants. Journal of Pediatrics2003;143(5):644‐8. ">Ravishankar 2003</a> where the rates were 86% and 72%); exogenous surfactant (stated in three trials: <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> where &gt; 90% received an artificial surfactant; <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a> where &gt; 80% received a natural surfactant; and <a href="./references#CD000501-bbs2-0010" title="WardleSP , HughesA , ChenS , ShawNJ . Randomised controlled trial of oral vitamin A supplementation to prevent chronic lung disease [abstract]. Pediatric Research1999;45:914. WardleSP ,  HughesA ,  ChenS ,  ShawNJ . Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Archives of Disease in Childhood Fetal and Neonatal Edition2001;84(1):F9‐F13. ">Wardle 2001</a> where all but one infant in the control group received an artificial surfactant); mode of ventilation including early nasal continuous positive airway pressure; postnatal steroids; and criteria for prescribing supplemental oxygen. </p> <p>Despite the variations among trials discussed above, the quality assessment of the body of evidence found in this review for the critical neonatal outcomes was judged to be of moderate quality. The effect of vitamin A on 28‐day outcomes (chronic lung disease or death, or both), death before 36 weeks' postmenstrual age, and chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors) is of moderate quality; therefore the possibility exists that the true effect is different than that estimated here and further research could change the estimates of the effects on these last outcomes. </p> <p>Less is known regarding follow‐up at 18 to 24 months. <a href="./references#CD000501-bbs2-0001" title="AmbalavananN ,  WuTJ ,  TysonJE ,  KennedyKA ,  RoaneC ,  CarloWA . A comparison of three vitamin A dosing regimens in extremely‐low‐birth‐weight infants. Journal of Pediatrics2003;142(6):656‐61. ">Ambalavanan 2003</a> assessed 85% of infants who participated in the study of <a href="./references#CD000501-bbs2-0009" title="AmbalavananN ,  TysonJE ,  KennedyKA ,  HansenNI ,  VohrBR ,  WrightLL ,  etal ,  National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics2005;115(3):e249‐54. LondheVA , NolenTL , DasA , HigginsRD , TysonJE , OhW , et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation in extremely low‐birth‐weight infants: subgroup analysis in small‐for‐gestational‐age infants. American Journal of Perinatology2013;30(9):771‐80. [DOI: 10.1055/s‐0032‐1333410] TysonJE , EhrenkranzRA , StollBJ , WrightLL , MeleL , KennedyKA , et al. Vitamin (Vit) A supplementation to increase survival without chronic lung disease (CLD) in extremely low birth weight (ELBW) infants: a 14‐center randomized trial [abstract]. Pediatric Research1998;43:199A. TysonJE ,  WrightLL ,  OhW ,  KennedyKA ,  MeleL ,  EhrenkranzRA , et al. Vitamin A supplementation for extremely‐low‐birth‐weight infants. National Institute of Child Health and Human Development Neonatal Research Network. New England Journal of Medicine1999;340(25):1962‐8. ">Tyson 1999</a>. Results regarding the long‐term effects that vitamin A could have on either neurodevelopment impairment (RR 0.89, 95% CI 0.74 to 1.08) or the combined outcome of death or neurodevelopmental impairment (RR 0.92, 95% CI 0.81 to 1.05) were inconclusive. The low quality of evidence for the neurodevelopment impairment makes evident the need for further research to define the long‐term effects of the supplementation of vitamin A in preterms. This trial was not powered appropriately to assess long‐term outcomes, and the benefit or harm from repeated intramuscular vitamin A following birth remains uncertain. </p> <p>The studies did not generally report the frequency or severity of adverse events, although <a href="./references#CD000501-bbs2-0006" title="PearsonE ,  BoseC ,  SnidowT ,  RansomL ,  YoungT ,  BoseG ,  etal . Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. Journal of Pediatrics1992;121(3):420‐7. ">Pearson 1992</a> noted that repeat intramuscular injections may have been painful. </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD000501-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram: review update" data-id="CD000501-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD000501-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.1 Death (before 1 month)." data-id="CD000501-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.1 Death (before 1 month). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.2 Chronic lung disease (oxygen use at 28 days in survivors)." data-id="CD000501-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.2 Chronic lung disease (oxygen use at 28 days in survivors). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.3 Death or chronic lung disease (oxygen use at 28 days)." data-id="CD000501-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.3 Death or chronic lung disease (oxygen use at 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.4 Death before 36 weeks' postmenstrual age." data-id="CD000501-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.4 Death before 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.5 Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors)." data-id="CD000501-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Supplemental vitamin A versus no supplementation, outcome: 1.5 Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 1 Death (before 1 month)." data-id="CD000501-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 1 Death (before 1 month). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 2 Chronic lung disease (oxygen use at 28 days in survivors)." data-id="CD000501-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 2 Chronic lung disease (oxygen use at 28 days in survivors). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 3 Death or chronic lung disease (oxygen use at 28 days)." data-id="CD000501-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 3 Death or chronic lung disease (oxygen use at 28 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 4 Death before 36 weeks' postmenstrual age." data-id="CD000501-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 4 Death before 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 5 Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors)." data-id="CD000501-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 5 Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 6 Death or chronic lung disease (oxygen use at 36 weeks' postmenstrual age)." data-id="CD000501-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 6 Death or chronic lung disease (oxygen use at 36 weeks' postmenstrual age). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 7 Death before 18 to 22 months." data-id="CD000501-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 7 Death before 18 to 22 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 8 Neurodevelopmental impairment at 18 to 22 months." data-id="CD000501-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 8 Neurodevelopmental impairment at 18 to 22 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 9 Death or neurodevelopmental impairment at 18 to 22 months." data-id="CD000501-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 9 Death or neurodevelopmental impairment at 18 to 22 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 10 Failure of ductal closure or treatment by day 14." data-id="CD000501-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 10 Failure of ductal closure or treatment by day 14. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 11 Sepsis (≥ 1 episodes)." data-id="CD000501-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 11 Sepsis (≥ 1 episodes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 12 Necrotising enterocolitis." data-id="CD000501-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 12 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 13 Intraventricular haemorrhage." data-id="CD000501-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 13 Intraventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 14 Periventricular leukomalacia." data-id="CD000501-fig-0021" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 14 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 15 Retinopathy of prematurity (any grade)." data-id="CD000501-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 15 Retinopathy of prematurity (any grade). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 16 Retinopathy of prematurity requiring laser therapy." data-id="CD000501-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Supplemental vitamin A versus no supplementation, Outcome 16 Retinopathy of prematurity requiring laser therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 1 Death before 36 weeks' postmenstrual age." data-id="CD000501-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 1 Death before 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 2 Oxygen use at 36 weeks' postmenstrual age in survivors." data-id="CD000501-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 2 Oxygen use at 36 weeks' postmenstrual age in survivors. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 3 Death or oxygen use at 36 weeks' postmenstrual age." data-id="CD000501-fig-0026" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 3 Death or oxygen use at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 4 Retinol concentration on study day 28 (μg/L)." data-id="CD000501-fig-0027" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 4 Retinol concentration on study day 28 (μg/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 5 Retinol &lt; 200 μg/L on day 28 (%)." data-id="CD000501-fig-0028" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 5 Retinol &lt; 200 μg/L on day 28 (%). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 6 Necrotising enterocolitis." data-id="CD000501-fig-0029" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 6 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 7 Retinopathy of prematurity (any grade)." data-id="CD000501-fig-0030" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 7 Retinopathy of prematurity (any grade). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 8 Retinopathy of prematurity (threshold disease)." data-id="CD000501-fig-0031" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 8 Retinopathy of prematurity (threshold disease). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 9 Sepsis (≥ 1 episodes)." data-id="CD000501-fig-0032" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks, Outcome 9 Sepsis (≥ 1 episodes). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 1 Death before 36 weeks' postmenstrual age." data-id="CD000501-fig-0033" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 1 Death before 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 2 Oxygen use at 36 weeks' postmenstrual age in survivors." data-id="CD000501-fig-0034" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 2 Oxygen use at 36 weeks' postmenstrual age in survivors. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 3 Death or oxygen use at 36 weeks' postmenstrual age." data-id="CD000501-fig-0035" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 3 Death or oxygen use at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 4 Retinol concentration on study day 28 (μg/L)." data-id="CD000501-fig-0036" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 4 Retinol concentration on study day 28 (μg/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 5 Retinol &lt; 200 μg/L on day 28 (%)." data-id="CD000501-fig-0037" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 5 Retinol &lt; 200 μg/L on day 28 (%). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 6 Necrotising enterocolitis." data-id="CD000501-fig-0038" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 6 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 7 Retinopathy of prematurity (any grade)." data-id="CD000501-fig-0039" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 7 Retinopathy of prematurity (any grade). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 8 Retinopathy of prematurity (threshold disease)." data-id="CD000501-fig-0040" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 8 Retinopathy of prematurity (threshold disease). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000501-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/urn:x-wiley:14651858:media:CD000501:CD000501-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_t/tCD000501-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 9 One or more episodes of sepsis." data-id="CD000501-fig-0041" src="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks, Outcome 9 One or more episodes of sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/media/CDSR/CD000501/image_n/nCD000501-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000501-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supplemental vitamin A compared to no supplementation in very low birth weight infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Supplemental vitamin A compared to no supplementation in very low birth weight infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> very low birth weight infants<br/> <b>Intervention:</b> supplemental vitamin A<br/> <b>Comparison:</b> no supplementation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> no supplementation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Supplemental vitamin A</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal death</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>168 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>144 per 1000<br/> (111 to 186) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86<br/> (0.66 to 1.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1165<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: 95% CI are wide and imprecise</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic lung disease (oxygen use at 28 days in survivors)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>725 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>674 per 1000<br/> (623 to 732) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93<br/> (0.86 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1070<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death or chronic lung disease (oxygen use at 28 days)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>798 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>742 per 1000<br/> (702 to 790) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.93<br/> (0.88 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1165<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death before 36 weeks' postmenstrual age</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>168 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>168 per 1000<br/> (129 to 216) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.00<br/> (0.77 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1089<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: 95% CI are wide and imprecise</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>546 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>486 per 1000<br/> (426 to 546) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.87<br/> (0.77 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>986<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death or chronic lung disease (oxygen use at 36 weeks' postmenstrual age)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>622 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>573 per 1000<br/> (523 to 629) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.92<br/> (0.84 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1089<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neurodevelopmental impairment at 18 to 22 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>481 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>428 per 1000<br/> (356 to 520) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.89<br/> (0.74 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>538<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Concerning imprecision: does not met the optimal information size criteria</i> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup><i>1</i> </sup><i>Imprecision: 95% CI are wide and imprecise</i> </p> <p><sup><i>2</i> </sup><i>Imprecision: although the 95% CI is narrow, the result is consistent with minimal clnical effect</i> </p> <p><sup><i>3</i> </sup><i>Concerning imprecision; does not met the optimal information size criteria</i> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Supplemental vitamin A compared to no supplementation in very low birth weight infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/full#CD000501-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000501-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Supplemental vitamin A versus no supplementation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death (before 1 month) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.66, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.62, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.56, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Chronic lung disease (oxygen use at 28 days in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.86, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>884</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.86, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Supplementation via intravenous route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.54, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.80, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death or chronic lung disease (oxygen use at 28 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.88, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.86, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.86, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Death before 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.77, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.77, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.56, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Chronic lung disease (oxygen use at 36 weeks' postmenstrual age in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.77, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>886</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.74, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.81, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Death or chronic lung disease (oxygen use at 36 weeks' postmenstrual age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.84, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.81, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.86, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Death before 18 to 22 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neurodevelopmental impairment at 18 to 22 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Death or neurodevelopmental impairment at 18 to 22 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Failure of ductal closure or treatment by day 14 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Sepsis (≥ 1 episodes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>947</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.76, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>947</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.76, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.67, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Any intraventricular haemorrhage</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>907</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.82, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Severe intraventricular haemorrhage (Grade 3 or 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1035</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.72, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Retinopathy of prematurity (any grade) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.65, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.42, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.75, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Retinopathy of prematurity requiring laser therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.55, 2.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Supplementation via intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [0.47, 7.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Supplementation via oral route</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.34, 2.96]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Supplemental vitamin A versus no supplementation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000501-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death before 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxygen use at 36 weeks' postmenstrual age in survivors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death or oxygen use at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Retinol concentration on study day 28 (μg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retinol &lt; 200 μg/L on day 28 (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity (any grade) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Retinopathy of prematurity (threshold disease) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Sepsis (≥ 1 episodes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vitamin A regimens: higher dose (10,000 IU) versus standard dose (5000 IU); both intramuscular and 3 x week for 4 weeks</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000501-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death before 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Oxygen use at 36 weeks' postmenstrual age in survivors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Death or oxygen use at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Retinol concentration on study day 28 (μg/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retinol &lt; 200 μg/L on day 28 (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Retinopathy of prematurity (any grade) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Retinopathy of prematurity (threshold disease) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 One or more episodes of sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vitamin A regimens: once‐a‐week (15,000 IU) versus standard dose (5000 IU 3 x week); both intramuscular and for 4 weeks</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000501.pub4/references#CD000501-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000501.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD000501-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000501-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000501-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD000501-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD000501-note-0002">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD000501-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD000501-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000501\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000501\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000501\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000501\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000501\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Ko3zGe0H&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000501.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000501.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000501.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000501.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000501.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725997480"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000501.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725997483"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000501.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e88e65ff99379',t:'MTc0MDcyNjAwMC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 